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Abstract 
Creatine supplementation is recommended as an ergogenic aid to improve repetitive 
sprint cycling performance. Creatine absorption is increased in the presence of electrolytes. The 
purpose of this study was to investigate the effect of a 6-week creatine-electrolyte (CE) 
supplementation intervention on peak power and total work performed during repeated cycling 
sprints. Peak power and total work performed by 38 recreational cyclists (CE group: n = 17; 23.4 
± 4.0 years; placebo (P) group: n = 18; 23.4 ± 4.0 years) were measured on a Velotron ergometer 
as they completed five, 15-s cycling sprints, with two minutes of recovery between sprints, pre- 
and post-supplementation. Peak power was the highest overall power measured across the 
sprints. Total work was the sum of the work performed across the five sprints. Participants’ body 
composition was estimated using three site skinfold measurements. Mixed-model ANOVAs 
were used for statistical analyses. A supplement-time interaction showed a 4% increase in peak 
power (27 W; p = 0.025) and a 5% increase in total work (1862 J; p = 0.023) from pre- to post-
supplementation for the CE group. For the P group, no differences were observed in these 
variables from pre- to post-testing. Similarly, the fat free mass increased by 2% (1.4 kg; p = 
0.001) from pre- to post-testing for the CE group, whereas no differences were found for the P 
group. For the CE group, a modest association (r = 0.626; p = 0.007) was observed between the 
increases in peak power and fat free mass from pre- to post-supplementation. A CE supplement 
improves repeated short duration cycling sprint performance when sprints are interspersed with 
adequate recovery periods. Additionally, the ergogenic effect of CE supplement is associated 
with an increase in lean body mass. 
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Chapter I 
The Problem and Its Scope 
Introduction 
 Cycling is a popular international sport with events varying in power output demands 
over different durations (Abbiss, Straker, Quod, Martin, & Laursen, 2010; Ebert et al., 2005; 
Ebert, Martin, Stephens, & Withers, 2006; Jeukendrup, Craig, & Hawley, 2000; Vogt et al., 
2006). In track cycling, events such as the individual and team sprint are shorter in distance and 
duration when compared to other cycling events, but require greater power outputs (Craig & 
Norton, 2001; Dorel et al., 2005). In other cycling events, such as road races, time trials, and 
criteriums, a cyclist must also provide high power output during mid-race attacks and sprints to 
the finish line (Abbiss et al., 2010; Ebert et al., 2005, 2006; Vogt et al., 2006). 
 The different energy systems of the human body each contribute to provide the energy 
required to generate power during cycling sprints (Jeukendrup et al., 2000; Smith & Hill, 1991). 
When energy demands are high, such as during cycling sprints, the phosphagen system uses 
phosphocreatine, in the creatine kinase reaction, to transfer a phosphoryl group to a molecule of 
adenosine diphosphate (ADP), producing adenosine triphosphate (ATP), and a creatine molecule 
(Gaitanos, Williams, Boobis, & Brooks, 1993; Glaister, 2005; Wyss & Kaddurah-Daouk, 2000). 
Conversely, when energy demands are low, such as during a recovery interval, the creatine 
kinase reaction will precede in the opposite direction, phosphorylating a creatine molecule, 
resynthesizing phosphocreatine, effectively storing energy for future use (Gaitanos et al., 1993; 
Wyss & Kaddurah-Daouk, 2000). Compared to the other energy systems, the phosphagen system 
is capable of providing energy turnover at the greatest rate (Chung et al., 1998). However, the 
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phosphagen system’s capacity to turnover energy at a high rate is limited (Bogdanis, Nevill, 
Boobis, & Lakomy, 1996; Jeukendrup et al., 2000; Smith & Hill, 1991). 
 Creatine supplementation is widely recommended as an ergogenic aid to improve 
performance during short bouts of high-intensity physical activity, such as cycling sprints 
(Bemben & Lamont, 2005; Demant & Rhodes, 1999; Mesa, Ruiz, González-Gross, Gutiérrez 
Sáinz, & Castillo Garzón, 2002; Turjung et al., 2000). Supplementation with creatine increases 
an individual’s total muscle creatine content (i.e. intramuscular phosphocreatine and creatine) 
(Ahmun, Tong, & Grimshaw, 2005; Greenhaff, Bodin, Soderlund, & Hultman, 1994; Harris, 
Söderlund, & Hultman, 1992; Hickner, Dyck, Sklar, Hatley, & Byrd, 2010; Preen et al., 2001; 
Yquel, Arsac, Thiaudière, Canioni, & Manier, 2002). The post-supplementation increase in 
intramuscular phosphocreatine leads to an increased degree that the phosphagen system may 
provide a rapid rate of energy turnover during cycling sprints, leading to increased power 
production while delaying the onset of fatigue (Bemben & Lamont, 2005; Demant & Rhodes, 
1999; Mesa et al., 2002; Turjung et al., 2000). Furthermore, the post-supplementation increase in 
intramuscular creatine availability increases the rate that phosphocreatine is resynthesized 
following the cessation of exercise (Greenhaff et al., 1994; Preen et al., 2001; Yquel et al., 2002), 
potentially leading to improved performance during subsequent sprints. Consequently, previous 
studies have investigated the effects of creatine supplementation on peak power output and total 
work performed during individual (Odland, MacDougall, Tarnopolsky, Elorriaga, & Borgmann, 
1997) and repetitive sprint cycling tests (Ahmun et al., 2005; Birch, Noble, & Greenhaff, 1994; 
Dawson et al., 1995; Finn et al., 2001; Preen et al., 2001; Snow et al., 1998; Tarnopolsky & 
MacLennan, 2000).  
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The composition of the creatine supplementation material plays a critical role in post-
supplementation effect on power generating capabilities. The majority of previous studies 
examining creatine supplementation and sprint cycling performance have used creatine 
monohydrate (Ahmun et al., 2005; Barnett, Hinds, & Jenkins, 1996; Birch et al., 1994; Cooke, 
Grandjean, & Barnes, 1995; Cottrell, Coast, & Herb, 2002; Dawson et al., 1995; Deutekom, 
Beltman, de Ruiter, de Koning, & de Haan, 2000; Havenetidis, Matsouka, Cooke, & Theodorou, 
2003; Jones, Atter, & George, 1999; Kinugasa et al., 2004; Odland et al., 1997; Okudan & 
Gokbel, 2005; Tarnopolsky & MacLennan, 2000; Vandebuerie, Vanden Eynde, Vandenberghe, 
& Hespel, 1998; Wiroth et al., 2001; Ziegenfuss et al., 2002). It is important to note, however, 
that creatine uptake is increased in the presence of electrolytes (Dai, Vinnakota, Qian, Kunze, & 
Sarkar, 1999; Guimbal & Kilimann, 1993; Peral et al., 2002; Snow & Murphy, 2001). Stout, 
Eckerson, Noonan, Moore, and Cullen (1999) reported eight-weeks of creatine-electrolyte 
supplementation led to significantly greater improvements in measurements of anaerobic power 
(i.e. bench press, vertical jump, and 100-meter sprint) when compared to supplementation with 
creatine alone. Additionally, when compared to the creatine-only and placebo groups, the 
creatine-electrolyte group demonstrated significantly greater increases in total body mass and fat 
free mass (Stout et al., 1999). These findings suggest that the ergogenic effect of creatine 
supplementation is enhanced when the creatine substance is taken in combination with 
electrolytes.  
However, with regards to creatine-electrolyte supplementation and repetitive sprint 
cycling performance, previous studies have failed to report significant increases in peak power 
output, and have reported mixed results with respect to changes in total work performed (Finn et 
al., 2001; Kreider et al.1998). Finn et al. (2001) investigated the effects of five days of creatine-
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electrolyte supplementation on peak and mean power outputs during four, 20-second cycling 
sprints, each interspersed with 20 seconds of recovery. While during the first 20-second sprint 
effort subjects demonstrated a trend toward significant improvements in peak and mean power 
outputs post-creatine-electrolyte supplementation, during no other sprint did the subjects 
demonstrate the same trend toward significant improvements in peak or mean power outputs 
(Finn et al., 2001). Following 28 days of creatine-electrolyte supplementation, Kreider et al. 
(1998) report significant increases in the amount of work performed during each of the first five 
of 12, six-second cycling sprints, each separated by 30 seconds of recovery. However, from 
sprints six to 12, the increases in work performed, per sprint for the creatine-electrolyte group 
were not significantly different from the increases observed following placebo treatment 
(Kreider et al., 1998). It is likely that the relatively short recovery durations (i.e. ≤ 30 seconds) 
utilized in the studies by Finn et al. (2001) and Kreider et al. (1998) did not allow for adequate 
intramuscular phosphocreatine resynthesis. Thus, decreasing the phosphagen system’s ability to 
contribute energy turnover during subsequent sprints. This would decrease the sensitivity of the 
cycling sprint testing protocol with respect to determining post-supplementation changes in peak 
power and total work performed. Bogdanis et al. (1998) reported that following 10- and 20-
second sprints, in a non-supplemented state, recovery intervals of two minutes allowed the 
resynthesis of phosphocreatine to about 86% and 76% resting levels, respectively. These findings 
suggest that an inter-sprint recovery interval of two minutes would allow for adequate recovery 
and increase the sensitivity of the cycling sprint testing protocol to detect post-supplementation 
performance improvements. However, no research has investigated the efficacy of creatine-
electrolyte supplementation on repeated sprint cycling performance when the sprints were 
interspersed with two minutes of recovery.  
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 The most commonly reported effect of creatine supplementation is a significant increase 
in total body mass, typically ranging between 1 – 3% (Burke et al., 2000; Cottrell et al., 2002; 
Dawson et al., 1995; Deutekom et al., 2000; Finn et al., 2001; Greenhaff et al., 1994; Hickner et 
al., 2010; Izquierdo, Ibanez, Gonzalez-Badillo, & Gorostiaga, 2002; Kinugasa et al., 2004; 
Kreider et al., 1998; Powers et al., 2003; Preen et al., 2001; Snow et al., 1998; Stout et al., 1999; 
Yquel et al., 2002; Ziegenfuss et al., 2002). Many of the studies reporting significant post-
supplementation increases in body mass utilize short duration creatine supplementation protocols 
(i.e. ≤ one week) (Cottrell et al., 2002; Dawson et al., 1995; Deutekom et al., 2000; Finn et al., 
2001; Greenhaff et al., 1994; Izquierdo et al., 2002; Kinugasa et al., 2004; Preen et al., 2001; 
Snow et al., 1998; Yquel et al., 2002; Ziegenfuss et al., 2002). As creatine is an osmotically 
active substance, it is likely that water retention (i.e. increased body water volume) accompanies 
increases in intramuscular creatine and phosphocreatine contents, contributing to the observed 
increases in total body mass (Powers et al., 2003). However, studies investigating longer 
duration (i.e. ≥ 28 days) creatine supplementation interventions have reported significant 
increases in fat free mass, typically ranging between 2 – 5% (Becque, Lochmann, & Melrose, 
2000; Kreider et al., 1998; Stout et al., 1999). These results suggest that another way creatine 
supplementation may elicit performance enhancement is by increasing fat free mass. However, 
no research has explored if changes in fat free mass are associated with improvements in sprint 
cycling performance. 
 The phosphagen system provides rapid energy turnover during sprints in cycling, though 
its capacity to do so is limited (Bemben & Lamont, 2005; Demant & Rhodes, 1999; Turjung et 
al., 2000). Supplementation with creatine increases resting intramuscular creatine and 
phosphocreatine concentrations (Ahmun et al., 2005; Finn et al., 2001; Greenhaff et al., 1994; 
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Harris et al., 1992; Hickner et al., 2010; Preen et al., 2001; Yquel et al., 2002), potentially 
leading to improved repetitive sprint cycling performance (Ahmun et al., 2005; Birch et al., 
1994; Cottrell et al., 2002; Dawson et al., 1995; Flanagan & Jakeman, 2006; Preen et al., 2001; 
Tarnopolsky & MacLennan, 2000; Vandebuerie et al., 1998; Ziegenfuss et al., 2002). The 
ergogenic effect of creatine supplementation may be enhanced when the creatine 
supplementation material is taken in combination with an electrolyte containing formula (Stout et 
al., 1999). However, no study has assessed the efficacy of six-weeks of creatine-electrolyte 
supplementation on repetitive sprint cycling performance when the sprint durations were equal to 
15 seconds, and the recovery intervals were greater than 30 seconds. Additionally, no research 
has explored if changes in body composition post creatine-electrolyte supplementation protocol 
are associated with improvements in sprint cycling performance.  
Purpose of the Study 
  The primary purpose of this study was to investigate the effect of a six-week creatine-
electrolyte supplementation intervention on peak power output and total work performed during 
repetitive, short duration sprint cycling performance, in a group of recreational cyclists. By 
employing sprint durations of 15 seconds and recovery intervals of two minutes, the ergogenic 
effect of creatine-electrolyte supplementation was assessed. In order to investigate underlying 
mechanisms associated with post-supplementation changes in peak power output and total work 
performed during five 15-second cycling sprints, body composition (i.e. percent body fat, fat 
mass, and fat free mass) and body water (i.e. total, intracellular, and extracellular water volumes) 
were assessed. 
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Experimental Hypothesis 
 It was hypothesized that six weeks of creatine and electrolyte supplementation would 
result in significant increases in peak power output and total work performed during repetitive, 
short duration sprint cycling performance. It was also hypothesized that creatine and electrolyte 
supplementation will result in significant increases in body mass, for which, significant increases 
in fat free mass and body water (i.e. total body, intracellular, and extracellular water volumes) 
would contribute.  
Significance of the Study 
 This study elucidates sprint cycling performance enhancements, post-creatine-electrolyte 
supplementation, in a group of recreational cyclists. This study adds to the literature by providing 
results with respect to changes in peak power output and total work performed during repetitive, 
short duration sprint cycling performance following a six-week creatine-electrolyte 
supplementation intervention. Changes in body mass, body composition (i.e. percent body fat, fat 
mass, and fat free mass), and body water (i.e. total body, intracellular, and extracellular water 
volumes) were analyzed following the same six-week creatine-electrolyte supplementation 
period.  
Limitations of the Study 
1. It was assumed that all subjects performed to the best of their ability during all testing 
procedures. Each subject was provided verbal encouragement to put forth a maximal effort 
during the testing procedures. 
2. The subjects were asked to maintain a consistent training status throughout the duration of 
their participation in this study; however, the researchers were unable to control the subjects’ 
compliance. 
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3. The supplementation protocol required the subjects to consume daily doses of their 
respective supplementation substance. The research team also could not control their 
compliance. Subjects who reported missing more than three doses were excluded from this 
study. 
4. The testing procedures were conducted in a laboratory setting on equipment that the 
subjects were not familiar with. The 5-minute warm-up period prior to the sprints was 
intended to familiarize the participants to cycling on the laboratory cycle ergometer.  
5. The results of this study are only applicable to young (19 – 33 yrs) male and female 
recreational cyclists, and only during similar testing protocol conditions.  
Definition of Terms 
Creatine (Cr): A nitrogenous molecule that is able to accept a phosphoryl group from ATP 
through the creatine kinase reaction (Walker, 1979). 
Creatine-Electrolyte (CE): A supplementation material comprised of about four grams of 
creatine, 286 mg magnesium chloride, 171 mg calcium chloride, 171 mg potassium 
chloride, and 114 mg sodium chloride (one daily dose). 
Phosphocreatine (PCr): The high-energy phosphorylated form of creatine, which is able to 
donate its phosphoryl group back to ADP through the creatine kinase reaction (Walker, 
1979). 
Total Creatine (TCr): The sum of creatine (Cr) and phosphocreatine (PCr) in the body (Delanghe 
et al., 1989). 
Peak Power Ouptut: The greatest one-tenth of a second average power achieved, in Watts (W), 
by a subject during any given 15-second sprint, pre- or post-supplementation. 
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Total Work: The total amount of work performed, in Joules (J), by each subject during five, 15-
second sprints (Ziegenfuss et al., 2002).  
Recreational Cyclist: Were defined by the author as persons who have participated in cycling 
activities (e.g. racing, recreation, commuting, indoor stationary cycle training) at least 
twice per week, for the previous six months. 
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Chapter II 
Review of Literature 
Introduction 
 Creatine supplementation is a common practice for athletes who are looking to increase 
their power output over short durations of time. However, previous research has demonstrated 
inconsistent results with respect to the efficacy of creatine supplementation. This chapter will 
introduce the reader to the key points of creatine and creatine supplementation, as well as 
provide evidence to support decisions for the supplementation protocol and testing procedures 
used in the current study. 
Review of Pertinent Literature 
 The role of creatine. Creatine (Cr) is a naturally occurring nitrogenous amino acid 
compound (Wyss & Kaddurah-Daouk, 2000). Total creatine refers to the absolute amount of 
creatine in the body, which can exist in either its basic form, creatine, or in the “high-energy” 
phosphorylated state of phosphocreatine (Bemben & Lamont, 2005). Phosphocreatine is a stored 
energy source in skeletal muscles that is involved in the creatine kinase reaction to generate 
energy (i.e. ATP) anaerobically. The creatine kinase reaction may be referred to as the 
phosphagen system, which is an anaerobic energy system that provides the cell with rapid rates 
of ATP synthesis during high intensity, short duration activities, such as sprint cycling (Gaitanos 
et al., 1993; Spencer, Bishop, Dawson, Goodman, & Duffield, 2006). The phosphagen system’s 
anaerobic energy production for cellular work occurs at a rapid rate, however, the phosphagen 
system has a limited capacity for the continued resynthesis of ATP (Chung et al., 1998; Smith & 
Hill, 1991). 
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 Endogenous synthesis and dietary intake of creatine.  Creatine is endogenously 
produced by a series of biological reactions involving the amino acids: glycine, arginine, and 
methionine in the kidney and the liver (Harris et al., 1992; Wyss & Kaddurah-Daouk, 2000). The 
first reaction take place in the kidney and the final reaction occurs in the liver, which then 
releases creatine into the bloodstream (Wyss & Kaddurah-Daouk, 2000). Creatine may also enter 
circulation through dietary intake (Peral et al., 2002). Foods such as meat and fish naturally 
contain creatine (Mesa et al., 2002).  
 Creatine in the body. The skeletal muscles contain nearly 95% of the total creatine 
content of the human body (Bemben & Lamont, 2005; Demant & Rhodes, 1999). The greatest 
proportion of one’s total creatine (61 – 69%) exists as phosphocreatine, while free creatine 
accounts for approximately 31 – 39% of total creatine (Bogdanis, Nevill, Boobis, & Lakomy, 
1996; Bogdanis, Nevill, Lakomy, & Boobis, 1998; Cottrell, Coast, & Herb, 2002; Harris, 
Hultman, & Nordesjö, 1974; Harris et al., 1992). Harris et al. (1974) estimated the average total 
muscle creatine content to be about 124.5 mmol × kg dry mass-1 in young adults. Normal plasma 
concentrations of creatine are low relative to muscle concentration, and range from 0.05 to 0.10 
mmol/L (Demant & Rhodes, 1999). The amount of creatine stored within the muscle cell 
compared to the bloodstream is about 500-1000%, creating a large concentration gradient (Dai et 
al., 1999). 
Creatine transport. Creatine transport is primarily dependent on specialized 
electrogenic creatine transporter proteins. To transport one creatine molecule into the cell, at 
least one chloride (Cl-) and two sodium (Na+) ions are needed (Dai, Vinnakota, Qian, Kunze, & 
Sarkar, 1999). Creatine entering the body through dietary intake is transported from the lumen of 
the small intestine, through the enterocytes, to the blood stream via these specialized electrogenic 
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creatine transporter proteins (Peral et al., 2002). Peral et al. (2002) report creatine uptake to be 
increased five-fold when rat small intestine cells are bathed in the presence of a Na+Cl- 
containing extracellular fluid, compared to when rat small intestine cells are bathed in an 
extracellular fluid without Na+Cl-. Once creatine has entered the bloodstream, either by 
endogenous synthesis or dietary intake, it circulates throughout the body until being actively 
transported into cells (e.g. muscle cells), again by way of an electrogenic creatine transporter 
protein (Snow & Murphy, 2001). 
 The creatine kinase reaction. Creatine is involved in the creatine kinase reaction, an 
enzymatically mediated biochemical reaction involved in the regulation of cellular energy 
metabolism (Chung et al., 1998; Greenhaff et al., 1994; Hespel, Op’t Eijnde, Derave, & Richter, 
2001). The creatine kinase reaction is provided below:  
 
 
Creatine + ATP    Phosphocreatine + ADP + H + 
 
During times of low energy demand, when the cellular ATP:ADP ratio is high, the 
creatine kinase reaction will favor the transfer of a phosphoryl group from a molecule of ATP, to 
a molecule of creatine (Wyss & Kaddurah-Daouk, 2000). Operating in this direction, the creatine 
kinase reaction forms one phosphocreatine and one ADP molecule, as well as a free hydrogen 
ion (H+) (Wyss & Kaddurah-Daouk, 2000). Phosphocreatine is an important biological 
compound that is able to store and transfer energy by binding a phosphoryl group (Greenhaff et 
al., 1994). Creatine accepts a phosphoryl group from ATP in the intermembrane space of the 
mitochondria, close to the mitochondrial matrix, the site of aerobic energy production (Wyss & 
Creatine Kinase 
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Kaddurah-Daouk, 2000). The phosphorylation of creatine in the intermembrane space of the 
mitochondria has benefits beyond the storage of energy in the form of phosphocreatine. The 
hydrogen ion released in the reaction increases the concentration of hydrogen ions in the 
intermembrane space, which may lead to increased ATP synthase activity (Erlanson-Albertsson, 
2003; Wyss & Kaddurah-Daouk, 2000). Additionally, the ADP molecule may reenter the 
mitochondrial matrix, increasing the level of ADP in the mitochondrial matrix, where it is a 
substrate in the reaction driven by hydrogen ion transport through ATP synthase (Erlanson-
Albertsson, 2003; Wyss & Kaddurah-Daouk, 2000). Phosphocreatine may then be shuttled out of 
the intermembrane space, and travel to a site of energy consumption within the cell. 
During times of increased energy demand, when the cellular ATP:ADP ratio is low, the 
creatine kinase reaction favors the transfer of a phosphoryl group from a molecule of 
phosphocreatine to ADP, producing an ATP and creatine molecule, while also consuming a 
hydrogen ion (Greenhaff et al., 1994; Wyss & Kaddurah-Daouk, 2000). This reaction is 
beneficial for the cell as it provides the rapid resynthesis of ATP, while buffering the decreasing 
pH of the intracellular environment by consuming a free hydrogen ion (Wyss & Kaddurah-
Daouk, 2000). 
 Creatine depletion and resynthesis. The depletion of creatine in the skeletal muscles 
increases with the duration of the cycling sprint. For example, for sprint durations lasting six to 
10 seconds, phosphocreatine levels deplete to 55 – 57% compared to resting levels when 
measured immediately post-sprint (Bogdanis et al., 1998; Gaitanos et al., 1993). With an increase 
in sprint duration to 20 and 30 seconds, the depletion of phosphocreatine increases to 73% and 
83%, respectively (Bogdanis et al., 1996; Bogdanis et al., 1998).  
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 During recovery, phosphocreatine is resynthesized within the cell. The degree to which 
phosphocreatine is resynthesized is an important consideration before beginning subsequent 
bouts of sprinting activities; and is dependent on the rate of resynthesis, and duration of the 
recovery interval. Previous investigations have shown that the rate of phosphocreatine 
resynthesis is higher in subjects in a creatine-supplemented compared to non-supplemented state 
for different types of exercises. Preen and colleagues (2001) investigated the rate of 
phosphocreatine resynthesis following a long-term sprint cycling exercise, before and after 
supplementing subjects with creatine. Following two minutes of passive recovery, 
phosphocreatine levels reached 97% of resting values in the supplemented state, increasing from 
the 89% phosphocreatine resynthesis reported during pre-supplementation testing. Similarly, 
Yquel et al. (2002) investigated the rate of phosphocreatine resynthesis after all-out dynamic 
plantar flexion exercises, and found the rate of phosphocreatine resynthesis to increase by 44% 
from non-supplemented to supplemented state in young healthy participants.  
 Consideration of duration of the recovery interval is also critical when investigating the 
degree of phosphocreatine resynthesis. With an increase in the duration of the rest interval, the 
degree to which phosphocreatine is resynthesized increases. For example, Greenhaff and 
colleagues (1994) examined the effect of 0, 20s, 60s, and 120s rest interval post intense 
electronically evoked isometric contractions and they found the rate of phosphocreatine 
resynthesis to increase systematically with increase the duration of rest interval. During the first 
minute of passive recovery, the rate of phosphocreatine resynthesis was similar to the pre-
supplementation state. However, during the second minute of recovery, subjects in the creatine-
supplemented condition demonstrated a 42% increase in the rate of phosphocreatine resynthesis 
(Greenhaff et al., 1994). 
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 Creatine supplementation and plasma and total muscle creatine. Supplementing with 
creatine increases the level of creatine in the blood stream, and allows for the greater uptake of 
creatine by skeletal muscle cells. Normal plasma creatine concentrations range from 50-100 
µmol/L (Demant & Rhodes, 1999). One hour after a single five gram dose of creatine 
monohydrate, peak plasma creatine concentrations have been shown to range between 690-1000 
pmol/L (Harris et al., 1992). The increase in circulating creatine enables the skeletal muscle 
creatine transporter proteins to bind with and transport more creatine into the cell. As the total 
muscle creatine content increases, so too does the content of phosphocreatine in skeletal muscle 
cells. Previous studies have shown creatine supplementation to increase total muscle creatine 
content from about 0.5 to 26% (Ahmun et al., 2005; Finn et al., 2001; Greenhaff et al., 1994; 
Harris et al., 1992; Hickner et al., 2010; Preen et al., 2001; Yquel et al., 2002). The increase in 
skeletal muscle phosphocreatine levels have been shown to range between 12 to 38% (Hickner et 
al., 2010; Preen et al., 2001; Yquel et al., 2002) 
 Common creatine supplementation protocols. Aspects of the creatine supplementation 
protocol (i.e. supplementation material and duration) may also play a critical role in post-
supplementation effect on sprint cycling performance. Many different creatine supplementation 
protocols have been used in creatine research studies. The most commonly used creatine 
supplementation protocols generally consists of a five to seven day loading period, with doses of 
four to five grams of creatine monohydrate, taken four to six times per day (Ahmun et al., 2005; 
Birch et al., 1994; Cooke et al., 1995; Cottrell et al., 2002; Dawson et al., 1995; Finn et al., 2001; 
Flanagan & Jakeman, 2006; Greenhaff et al., 1994;  Kinugasa et al., 2004; Nelson et al., 2000; 
Okudan & Gokbel, 2005; Oliver, Joubert, Martin, & Crouse, 2013; Preen et al., 2001; Snow et 
al., 1998; Tarnopolsky & MacLennan, 2000; Yquel et al., 2002). Studies using these creatine-
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loading protocols have reported increases in total muscle creatine content ranging from about 
0.5% to 26%. Although these creatine-loading protocols are the most commonly used, some 
studies have employed different creatine supplementation protocols. 
 Hickner et al. (2010) supplemented 12 endurance-trained cyclists with three grams of 
creatine monohydrate per day, for 28 days. Muscle biopsies taken before and after the creatine 
supplementation intervention revealed a total muscle creatine content increase of about 25%. 
These results suggest that a low-dose, long duration (in this case 28 days), creatine 
supplementation protocol can be as effective as a creatine loading protocol at increasing total 
muscle creatine. To determine the efficacy of different creatine supplementation protocols on 
total muscle creatine content, Harris et al. (1992) provided subjects with different 
supplementation protocols with respect to daily doses and intervention duration. Subjects in the 
study received either 4 × 5 g/day, 6 × 5 g/day, or 6 × 5 g/every other day of creatine 
monohydrate, for durations lasting between 3.5 to 21 days. The average increase in total muscle 
creatine content for all protocols combined was about 17% post-creatine supplementation, with 
no one supplementation protocol shown to increase total muscle creatine more than another. 
Harris and colleagues (1992) suggest the initial total creatine content of the subject to be more 
important than the daily dosing quantity, rate, or intervention duration, noting that the greatest 
increases in total creatine content were in subjects with the lowest pre-intervention total creatine 
content. While some subjects substantially increased their total creatine content through 
supplementation, the highest values for total muscle creatine peaked around 155 mmol × kg dry 
mass-1, suggesting an upper limit for total muscle creatine content. 
 It is important to note, however, that creatine uptake is increased in the presence of 
electrolytes (Dai et al., 1999; Guimbal & Kilimann, 1993; Peral et al., 2002; Snow & Murphy, 
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2001). Investigators (Stout et al., 1999) report eight-weeks of creatine-electrolyte 
supplementation to lead to significantly greater improvements in measurements of anaerobic 
power (i.e. bench press, vertical jump, and 100-meter sprint) when compared to supplementation 
with creatine alone. Additionally, when compared to the creatine-only and placebo groups, the 
creatine-electrolyte group demonstrated the greatest increases in fat free mass and overall body 
mass post-supplementation (Stout et al., 1999). These findings suggest that the ergogenic effect 
of creatine supplementation is enhanced when the creatine substance is taken in combination 
with electrolytes. 
 Creatine supplementation and body mass, body composition, and body water 
volumes. The most commonly reported side effect of creatine supplementation is an increase in 
body mass, typically ranging between 1% – 3% (0.8 – 2.2 kg) (Burke et al., 2000; Cottrell et al., 
2002; Deutekom et al., 2000; Finn et al., 2001; Greenhaff et al., 1994; Hickner et al., 2010; 
Kinugasa et al., 2004; Kreider et al., 1998; Powers et al., 2003; Preen et al., 2001; Snow et al., 
1998; Yquel et al., 2002). Some studies have also reported significant, but lesser (i.e. > 1%), 
increases in body mass, post-supplementation with creatine (Dawson et al., 1995; Izquierdo et 
al., 2002; Ziegenfuss et al., 2002). While others have reported no significant post-
supplementation increases in body (Ahmun et al., 2005; Barnett et al., 1996; Green, McLester, 
Smith, & Mansfield, 2001; Okudan & Gokbel, 2005; Wiroth et al., 2001). The relatively short 
duration of the studies utilizing creatine-loading protocols indicates that early increases in body 
mass are likely not due to protein synthesis (i.e. muscle hypertrophy) (Abe, DeHoyos, Pollock, & 
Garzarella, 2000; DeFreitas, Beck, Stock, Dillon, & Kasishke, 2011; Seynnes, de Boer, & Narici, 
2007). Instead, the increases in total body mass in these studies is likely related to the absorption 
of creatine, and the water retention that accompanies it (Hultman, Söderlund, Timmons, 
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Cederblad, & Greenhaff, 1996; Powers et al., 2003). It is worth noting that all of the studies 
reporting little to no increases in body mass (i.e. > 1%) following creatine supplementation have 
utilized creatine-loading supplementation protocols, with supplementation interventions lasting 
less than one week. Of the studies reporting significant post-creatine supplementation increases 
in body mass, the greatest increases in body mass are reported when the supplementation 
durations are equal to or greater than 21 days. For example, following 21 days of creatine 
supplementation, Burke et al. (2000) report a 2.4% increase in body mass. Following 28 days of 
creatine supplementation, Hickner et al. (2010) and Kreider et al. (1998) report increases in their 
subjects’ body masses of 2.6% and 2.4%, respectively. Combined, these results suggest that 
one’s total body mass will likely increase beyond one week of supplementation with creatine. 
Short duration supplementation protocols, therefore, may be more prone to missing post-
supplementation increases in total body mass.  
 In order to investigate the effect of creatine supplementation on total muscle creatine 
content, body mass, total body water, and fluid distribution, Powers et al. (2003) supplemented 
16 subjects with creatine monohydrate for a total intervention period of 28 days. Post-creatine 
supplementation, the subjects demonstrated increases in total muscle creatine content, body 
mass, and total body water of approximately 16.6%, 1.8%, and 4.9%, respectively (Powers et al., 
2002). The average increase in total body water equaled 2.04 liters, post-creatine 
supplementation. Intracellular water increased by 1.13 liters (about 4.6% increase), while 
extracellular water increased by .91 liters (about 5.2% increase). Based on these results, Powers 
et al. (2002) suggest that creatine supplementation increases muscle creatine content, body mass, 
and total body water; however, does not alter fluid dynamics.  
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 Investigators Kreider et al. (1998) also report a significant increase in body mass 
following 28 days of creatine-electrolyte supplementation, however, Kreider et al. (1998) report 
no significant changes in total body water volume . Instead, following 28 days of creatine-
electrolyte supplementation, Kreider et al., (1998) report significant post-supplementation 
increases in total body mass to be accompanied by significant increases in fat free mass. 
Similarly, after eight weeks of creatine-electrolyte supplementation, Stout et al., (1999) report 
significant increases in their subjects’ total body and fat free masses.  
 Performance enhancement elicited by creatine supplementation. Research studies 
examining the magnitude of improvement in sprint cycling performance post-creatine 
supplementation, however, have reported inconsistent results. Some studies have reported 
improvements in peak power output ranging from 2 – 9% (Ahmun et al., 2005; Birch et al., 
1994; Cottrell et al., 2002; Dawson et al., 1995; Flanagan & Jakeman, 2006; Preen et al., 2001; 
Tarnopolsky & MacLennan, 2000; Vandebuerie et al., 1998; Ziegenfuss et al., 2002) and 
increases in total work ranging between 5 – 9% (Preen et al., 2001; Vandebuerie et al., 1998; 
Wiroth et al., 2001; Ziegenfuss et al., 2002). Other studies have demonstrated little or no 
ergogenic effect from creatine supplementation (Barnett et al., 1996; Cooke et al., 1995; 
Deutekom et al., 2000; Finn et al., 2001; Green et al., 2001; Kinugasa et al., 2004; Odland et al., 
1997; Snow et al., 1998). Inconsistencies between the elicited performance improvements, post-
creatine supplementation, are likely associated with inter-study differences in the methods 
employed, including aspects of the sprint-cycling (i.e. sprint and recovery interval durations) and 
supplementation protocols (i.e. supplementation material and duration). 
Effects of the sprint and recovery durations. Aspects of the cycling sprint protocol (i.e. 
sprint and recovery interval durations) are necessary to consider when testing the efficacy of 
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creatine supplementation. Sprint durations of ranging from six to 30 seconds are frequently used 
when examining the ergogenic effect of creatine supplementation during sprint cycling sprints 
(Ahmun et al., 2005; Birch et al., 1994; Dawson et al., 1995; Deutekom et al., 2000; Finn et al., 
2001; Jones et al., 1999; Odland et al., 1997; Okudan & Gokbel, 2005; Preen et al., 2001; Wiroth 
et al., 2001). When measured immediately post-sprint, sprint durations lasting six to 10 seconds 
deplete resting intramuscular phosphocreatine concentrations by 55 – 57% (Bogdanis et al., 
1998; Gaitanos et al., 1993). With an increase in sprint duration to 20 and 30 seconds, the 
depletion of phosphocreatine increases to 73% and 83%, respectively (Bogdanis et al., 1996; 
Bogdanis et al., 1998). Smith and Hill (1991), however, concluded that during a 30-second 
Wingate power test, only 28% of energy demands were met by the phosphagen system, whereas 
the remaining 72% of energy demands were met by glycolysis and aerobic respiration. Sprint 
durations of 20 – 30 seconds rely heavily on the glycolytic energy system, thus, decreasing the 
efficacy of the test to elicit performance enhancements post-creatine supplementation (Bogdanis 
et al., 1996, 1998; Smith & Hill, 1991). Therefore, sprint durations of 20 – 30 second may not be 
appropriate for examining the capacity of the phosphocreatine system. 
 Because phosphocreatine is resynthesized during the recovery intervals separating 
cycling sprints, the duration of the recovery intervals is a critical factor when examining the 
effect of creatine supplementation on peak power output and total work performed during 
repetitive bouts of sprint cycling (McMahon & Jenkins, 2002; Tomlin & Wenger, 2001). The 
duration of the recovery intervals used in the majority of studies ranges from 15 seconds to six 
minutes (Ahmun et al., 2005; Birch et al., 1994; Deutekom et al., 2000; Finn et al., 2001; 
Havenetidis et al., 2003; Jones et al., 1999). However, following near total intramuscular 
phosphocreatine depletion, a recovery duration of only 20 seconds allows for phosphocreatine 
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resynthesis to less than 30% of its resting level (Greenhaff et al., 1994). Following 10- and 20-
second sprints, in a non-supplemented state, recovery intervals of two minutes allowed the 
resynthesis of phosphocreatine to about 86% and 76% resting levels, respectively (Bogdanis et 
al., 1998). Greenhaff et al. (1994) determined the post creatine supplementation rate of 
phosphocreatine resynthesis to show the greatest increase during the second minute of recovery, 
about 42% increased compared to pre-supplementation. 
Effects of other aspects of the sprint cycling protocol on performances outcomes.  
Previous studies investigating peak power output during sprint cycling have utilized different 
cycle ergometers, including: mechanically-braked (e.g. Monark) (Ahmun et al., 2005; Bogdanis 
et al., 1996, 1998; Flanagan & Jakeman, 2006; Green et al., 2001; Odland et al., 1997; Okudan & 
Gokbel, 2005; Tarnopolsky & MacLennan, 2000; Vandebuerie et al., 1998; Wiroth et al., 2001; 
Ziegenfuss et al., 2002); air-braked (e.g. Repco and Evolution) (Dawson et al., 1995; Finn et al., 
2001; Preen et al., 2001; Snow et al., 1998; Spencer et al., 2006); and electronically-braked (e.g. 
Velotron) (Abbiss, Quod, Levin, Martin, & Laursen, 2009; Astorino & Cottrell, 2012; Clark, 
2015; Lopez, Smoliga, & Zavorsky, 2014) cycle ergometers. Additionally, isokinetic cycle 
ergometers with constant pedaling cadences of 80 rpm (Birch et al., 1994) and 120 rpm 
(Karatzaferi, de Haan, Ferguson, van Mechelen, & Sargeant, 2001) have been used for the 
measurement of power output during sprint cycling. However, peak power output varies in 
magnitude when measured on different cycle ergometer types. Astorino and Cottrell (2012) 
report the Velotron cycle ergometer to provide reliable peak power output values, though, when 
all other testing variable are held constant, significantly higher when compared to power outputs 
achieved on a mechanically-braked Monark cycle ergometer. Similarly, Abbiss, Quod, Levin, 
Martin, and Laursen (2009) report significant inter-ergometer (i.e. Velotron and SRM power 
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meter) variations in measured power output values, especially during dynamic and high-intensity 
cycling. 
 Beyond the type of cycle ergometer used, other aspects of the sprint cycling protocol, 
including the magnitude of the resistive load applied to the flywheel, starting technique, and 
sprint cycling posture, contribute to variations in measured peak and mean powers (Clark, 2015; 
Dotan & Bar-Or, 1983; Lopez et al., 2014; Millet, Tronche, Fuster, & Candau, 2002; Reiser, 
Maines, Eisenmann, & Wilkinson, 2002). 
 Significant intra-ergometer cycling sprint power output differences result from changes in 
the magnitude of the resistive load applied to the flywheel during the sprint (Dotan & Bar-Or, 
1983; Vandewalle, Pérès, Heller, & Monod, 1985), further contributing to inter-study peak 
power output differences. The resistive load applied to the flywheel in previous studies 
investigating peak power output during sprint cycling is typically calculated relative to the 
subject’s body mass, and generally ranges between 0.060 and 0.100 kilogram per kilogram of 
body mass, or 6 – 10% of the subject’s body mass (Bogdanis et al., 1996, 1998; Flanagan & 
Jakeman, 2006; Green et al., 2001; Okudan & Gokbel, 2005; Robergs et al., 2015; Tarnopolsky 
& MacLennan, 2000; Ziegenfuss et al., 2002). Absolute resistive loads (i.e. predetermined 
resistive loads, regardless of the subject’s body mass) have also been used (Cooke et al., 1995; 
Vandebuerie et al., 1998). For example, investigators Vandebuerie et al. (1998) used an absolute 
resistive load of 6 kg, averaging 8.1% of their subjects’ body mass, while Cooke et al. (1995) 
used an absolute resistive load of 11.4 kg, averaging 14% of their subjects’ body mass. Results 
from the studies by investigators Dotan and Bar-Or (1983) and Vandewalle et al. (1985) indicate 
that relative resistive loads around 9 – 10% body mass tend to result in the greatest measured 
peak and mean power outputs during sprint cycling. Therefore, the resistive load used in the 
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present study may have contributed to the relatively low peak power outputs observed when 
compared to the results of previous studies reporting mean peak power outputs above 1,000 
watts, each using resistive loads between 8% and 10% body mass (Green et al., 2001; Ziegenfuss 
et al., 2002). 
 The method used to enter the cycling sprint (i.e. flying versus stationary start) also 
influences the resulting peak power output, as flying starts tend to lead to greater peak power 
outputs when compared to stationary starts (Clark, 2015; Robergs et al., 2015). Some previous 
sprint cycling studies utilize flying starts, where the subjects typically pedal at cadences equal to 
or greater than 60 revolutions per minute, against a flywheel with no additional external 
resistance applied, for five to six seconds (Ahmun et al., 2005; Astorino & Cottrell, 2012; 
Bogdanis et al., 1996, 1998; Clark, 2015; Green et al., 2001; Odland et al., 1997; Okudan & 
Gokbel, 2005; Reiser et al., 2002; Robergs et al., 2015). Other studies have utilized stationary 
starts, where the subjects initiate the sprint testing from a standstill, with the resistive load for the 
test applied to a motionless flywheel (Deutekom et al., 2000; Kinugasa et al., 2004; Spencer et 
al., 2006). In the study by Robergs et al. (2015), when subjects entered the test with a flying start 
(i.e. five seconds of pedaling at their maximal cadence, with no additional resistance against the 
flywheel) peak power output was measured within the first second of initiating the test and 
applying resistance to the flywheel (Robergs et al., 2015). With a flying start, the subjects’ power 
outputs rapidly decreased during the first two seconds of the sprint, and gradually decreased 
beyond that point, resulting in a constantly negatively sloping power output over time curve 
(Robergs et al., 2015). Investigators Robergs et al. (2015) conclude that the flying start protocol 
they used lead to overestimations of the indiviual’s peak power output (Robergs et al., 2015). 
However, when the same subjects entered the sprint from a stationary start, their power outputs 
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increased gradually, until around nine seconds into the test, when peak power output was 
achieved, then gradually decreasing from there (Robergs et al., 2015). The peak power outputs 
measured between the sprints with the flying and stationary starts were significantly different, 
with the peak power outputs being significantly higher during the flying start condition (Robergs 
et al., 2015). Sprint cycling posture also affects peak and mean power output values. When 
compared to seated sprints, standing sprints result in significantly greater peak and mean power 
outputs (Millet et al., 2002; Reiser et al., 2002).  
 An appropriate test to assess the post-creatine supplementation performance 
enhancement. To determine the efficacy of creatine supplementation at improving sprint cycling 
performance, a test consisting of short periods of maximal work (e.g. sprint cycling), with 
intermittent periods of recovery should be used (Cooke et al., 1995; Demant & Rhodes, 1999; 
Spencer et al., 2006). Gaitanos et al. (1993) report a 57% depletion of phosphocreatine following 
a six-second sprint. Similarly, Bogdanis et al. (1998) reported a 55% and a 73% decrease in 
phosphocreatine after a 10- and 20-second sprint, respectively. Following a 30-second maximal 
sprint on a cycle ergometer, Bogdanis and colleagues (1996) reported a reduction in 
intramuscular phosphocreatine of about 83%. Therefore, the rate of phosphocreatine depletion of 
over time demonstrates an initially fast component (~ 15 seconds), when the phosphagen system 
has the greatest amount of stored phosphocreatine, and is able to provide the greatest magnitude 
of energy turnover, followed by a slower component (> 15 seconds), when there is a gradual 
decrease in the rate of phosphocreatine depletion over time, as phosphocreatine stores become 
further depleted (Glaister, 2005; Yquel et al., 2002). In order to ideally examine the capacity of 
the phosphagen system during sprint cycling, investigators Cottrell, Coast, and Herb (2002) 
suggest employing sprint durations of 15 seconds. 
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 Similarly, the rate at which phosphocreatine is resynthesized following high intensity 
exercise also demonstrates a fast and slow component, as the majority of phosphocreatine is 
resynthesized within the first two minutes of recovery, followed by a decreased rate in the 
resynthesis of phosphine creatine as phosphocreatine levels approach resting values (i.e. beyond 
two minutes) (Glaister, 2005; Greenhaff et al., 1994; Yquel et al., 2002). Additionally, because 
of the effect of creatine supplementation to increase the rate of phosphocreatine, and considering 
the greatest increase in the rate of phosphocreatine resynthesis occurs during the second minute 
of recovery, multiple bouts of maximal sprint cycling should be interspersed with about two 
minutes of recovery (Greenhaff et al., 1994; Preen et al., 2001; Yquel et al., 2002). Therefore, to 
investigate the efficacy of a six-week, low-dose creatine-electrolyte supplementation protocol, a 
testing procedure consisting of five, 15-second cycling sprints, each interspersed with two 
minutes of passive recovery, was used in the present study. Therefore, the ergogenic effect of 
creatine supplementation is likely to be elicited during repetitive bouts of short duration (i.e. 15 
seconds) sprint cycling, when interspersed with two minutes of recovery. 
Summary 
 Creatine is a biological compound involved in cellular energy balance (Chung et al., 
1998). Creatine is endogenously synthesized, as well as taken in through the consumption of 
meat and fish (Walker, 1979). Once creatine enters the bloodstream, primarily muscle cells, by 
way of an electrogenic, take it up (Dai et al., 1999). Inside the cell, creatine may be 
phosphorylated, becoming phosphocreatine (Wyss & Kaddurah-Daouk, 2000). In times of 
increased energy demand, phosphocreatine can donate its phosphoryl group to ADP, producing 
ATP while buffering the intracellular environment by consuming a hydrogen ion in the creatine 
kinase reaction (Wyss & Kaddurah-Daouk, 2000). During bouts of maximal intensity exercise, 
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the level of intracellular phosphocreatine will decrease, first rapidly (about 0 – 10 seconds), then 
more slowly (> 10 seconds) (Bogdanis et al., 1996; Bogdanis et al., 1998; Preen et al., 2001). 
Following the cessation of exercise, phosphocreatine is resynthesized, which happens at a greater 
rate following creatine supplementation (Greenhaff et al., 1994; Preen et al., 2001; Yquel et al., 
2002). Creatine supplementation, regardless of the protocol employed, increases total muscle 
creatine and phosphocreatine contents (Harris et al., 1992). The increase in body mass commonly 
reported as a result of creatine supplementation is primarily due to increases in body water 
volumes (Powers et al., 2003) and/or fat free mass (Kreider et al., 1998; Stout et al., 1999). 
Previous studies have shown inconsistent results with regard to peak power output and total 
work, post-creatine supplementation (Bemben & Lamont, 2005). In light of the data collected 
from the current review of literature, this study will investigate the effect of a six-week, low-dose 
creatine-electrolyte supplementation protocol, by utilizing a testing procedure consisting of five, 
15-second sprints, interspersed with two minutes of passive recovery. 
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Chapter III 
Methods and Procedures 
Introduction 
The primary purpose of this study was to determine if creatine and electrolyte 
supplementation improves repetitive 15-second sprint cycling performance, measured by peak 
power output and total work performed, more than the placebo condition, in a group of 
recreational cyclists. The secondary purpose of this study was to assess the effect of creatine and 
electrolyte supplementation on changes in body mass, body composition, and body water. In 
order to do this, a randomized double blind placebo controlled study was conducted. 
Description of Study Population 
 Thirty-eight healthy subjects, between the ages of 19 – 33 years, were recruited for this 
study. Subjects were randomly chosen from those who responded to recruitment flyers posted 
around Western Washington University’s campus, and at bike shops in Bellingham, Washington. 
Subjects were also solicited from kinesiology and psychology classes on the Western 
Washington University campus. All subjects were recreational cyclists, participating in cycling 
activities (e.g. racing, recreation, commuting, indoor stationary cycle training) at least twice per 
week, for the previous six months. Subjects were excluded from the current study if they had 
supplemented with creatine in the 60 days prior to pre-intervention testing. Additional 
exclusionary criteria included: a history of kidney, liver, or endocrine disease or dysfunction, 
and/or any other disorder that might affect normal cellular levels of creatine or fluid balance. 
Prior to participation in the current study, all subjects received and signed an informed consent 
form, which had been previously approved by the institution’s Human Subjects Committee, in 
accordance with the Department of Health and Human Services guidelines. 
  	
 
28	
Design of the Study 
 The study was a randomized double blind placebo control intervention where differences 
in sprint cycling performance were examined pre- and post-six-week supplementation with either 
creatine and electrolytes or placebo materials. Upon volunteering for the study, subjects were 
randomly assigned to one of two groups, a creatine-electrolyte and a placebo group, before they 
completed initial testing. Pre-supplementation (PRE) testing was followed by a six-week 
intervention period, during which participants supplemented either with creatine and electrolytes 
or placebo materials, depending on their group assignment. Subjects then completed post-
supplementation (POST) testing, which consisted of identical testing procedures as pre-
supplementation testing. Differences in peak power output and total work performed during 
sprint cycling; body mass; body composition (i.e. percent body fat, fat mass, and fat free mass); 
and body water volumes (i.e. total body, intracellular, and extracellular water volumes) were 
examined from pre- to post-supplementation testing (within groups) and between the creatine-
electrolyte and placebo groups (between groups). 
Data Collection Procedures 
 Instrumentation. The subjects’ weight and height were measured using a standard 
balance beam scale with stadiometer (Detecto, Webb City, MO). The subjects’ body water (i.e. 
total body, intracellular, and extracellular water) were determined using a Quantum X 
Bioelectrical Body Composition Analyzer (RJL Systems, Clinton, MI), a method previously 
shown to be valid and reliable (Haas et al., 2012; Segal et al., 1991). Body composition was 
assessed using a Vital Signs Model 68910 skinfold caliper (Country Technology, Gays Mills, 
WI) using skinfold thickness measurement technique, a valid and reliable method for the 
assessment of body composition (Scherf, Franklin, Lucas, Stevenson, & Rubenfire, 1986). A 
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Velotron electronically-braked cycle ergometer (Racer-Mate Inc., Seattle, WA) interfaced with 
its corresponding Velotron Wingate software (Racer-Mate Inc., Seattle, WA) was used to 
measure power output and work performed, at a sampling frequency of 10 Hz, during sprint 
cycling testing. The Velotron cycle ergometer is a reliable instrument for measuring power 
output during sprint cycling (Abbiss et al., 2009; Astorino & Cottrell, 2012), and has been 
previously used to investigate variables of sprint cycling (Clark, 2015; Lopez et al., 2014). In 
order to determine macronutrient and total energy intake, three-day diet records were recorded 
by the subjects, and subsequently entered into Nutritionist Pro software (Axxya Systems, 
Stafford, TX). The Bouchard Three-Day Physical Activity Record (Bouchard et al., 1983) was 
used to predict total energy expenditure during the same three-day period that three-day diet 
records were recorded. 
 Measurement techniques and procedures. Prior to participation in the current study, 
subjects were provided with and signed an informed consent form, which had previously been 
approved by the University’s Institutional Review Board. Following the receipt and signing of 
the informed consent form, the subjects completed a medical history form. Prior to continuing 
with testing, each subject’s medical history form was reviewed for conditions that may affect 
outcomes of the study, including: recent injuries; a history of kidney, liver, or endocrine disease 
or dysfunction; and/or any other disorder that might affect normal cellular levels of creatine or 
fluid balance. Upon confirming the subjects met the criteria for participation, they were provided 
with standardized clothing, which included cycling shoes, shorts, and a top. Subjects changed 
into the standardized clothing before continuing with testing. The subjects’ weight and height 
were measured in pounds and inches, respectively, using a standard balance beam scale with 
stadiometer. While measuring the subjects’ weight and height, the subjects were instructed to 
  	
 
30	
remove their shoes and socks, and stand as tall as possible, with feet together and their hands 
placed on their hips. The subjects’ weight was converted from pounds to kilograms by 
multiplying their weight in pounds by 0.454, and their height in inches was converted to meters 
by multiplying their height in inches by 0.00254.  
 For the assessment of total body, intracellular, and extracellular water, a Quantum X 
Bioelectrical Body Composition Analyzer was used in accordance with the manufacturer’s 
recommended procedures. Briefly, after ensuring the subject had recently emptied their bladder, 
the subject was instructed to lie on a testing table in the supine position with their arms and legs 
abducted to approximately 30°, and their hands placed palm down on the testing table surface. 
Prior to placing adhesive electrodes on the intended electrode locations, the sites were cleaned 
with an alcohol wipe and allowed to air dry for about 30 seconds. Two electrodes were placed on 
the subject’s right hand (one placed in line with the ulnar head and the other placed on the 
proximal phalanx of the middle finger), and two electrodes were placed on the subject’s right 
foot (one placed in line with the medial malleolus and the other placed at the base of the second 
toe). The Quantum X Bioelectrical Body Composition Analyzer was then connected to the 
electrodes. The resistance and reactance of the subject’s body to an alternating current (50 Khz) 
were measured and recorded. Total body, intracellular, and extracellular water were determined 
using an online calculator provided by the manufacturer of the Quantum X Bioelectrical Body 
Composition Analyzer (“Interactive Online BIA,” n.d.). The online calculator required the 
subject’s height, mass, age, gender, resistance, reactance, frame size, and activity level to be 
entered. The subjects’ frame size and activity level were always entered as “large” and “heavy”, 
respectively. 
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 For the assessment of body composition variables, the subjects’ body density was first 
determined using sex-specific a three-site skinfold thickness measurement technique (Pescatello, 
2014, Box 4.3, p. 69). For male subjects, the three sites included the chest, abdomen, and thigh. 
For female subjects, the three sites included the triceps, suprailiac, and thigh. The exact skinfold 
locations and orientations were measured using methods described previously (Pescatello, 2014, 
Box 4.2, p. 68). All skinfold sites were measured on the subject’s right side. The skinfold 
calipers were placed one centimeter away from the index finger and thumb used to create the 
skinfold, and the measurement was taken within one to two seconds of placing the skinfold 
calipers on the site perpendicular to the skinfold. All three sites were measured once before 
rotating back through for duplicate site measurements. Skinfold thickness was measured at least 
twice at each location. If the first and second skinfold thickness measurement for any site 
deviated by more than two millimeters, a third measurement was made, and the inconsistent 
measurement was discarded. During no testing session were more than three measurements per 
site required. The means of the two consistent skinfold thickness measurements for each site 
were calculated and used accordingly in subsequent equations to determine body density 
(Pescatello, 2014, Box 4.3, p. 69). The subject’s percent body fat was calculated using the Siri 
model, where percent body fat equaled 495 divided by body density, minus 450 (Pescatello, 
2014, p. 70). The subject’s fat free mass and fat mass were calculated using the subject’s total 
body mass and estimated percent body fat. 
 Prior to sprint cycling testing, an ergometer set-up procedure was performed to 
standardize the cycling position of participants because posture is known to affect energy cost 
(Nordeen-Snyder, 1977), joint ranges of motion, and muscle activation patterns (Sanderson & 
Amoroso, 2009). Seat height, which was defined as the distance from the top of the saddle to 
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pedal surface, was set at 100% of trochanteric length (Nordeen-Snyder, 1977). Handlebar height 
was set at the same level as seat height. Seat fore-aft position was set such that when the crank 
arms were horizontal, a plumb line dropped from the inferior pole of the patella of the forward 
leg hung directly over the pedal axle (Silberman, Webner, Collina, & Shiple, 2005). Finally, 
handlebar fore-aft position was modified to achieve a trunk angle of 30° (Ericson, Bratt, Nisell, 
Arborelius, & Ekholm, 1986; Korff, Newstead, Zandwijk, & Jensen, 2014).  
 The subjects then completed a five-minute self-selected warm-up on the Velotron cycle 
ergometer, where they were able to choose their own cadence and resistance. Three minutes of 
passive recovery, where the subjects remained seated on the Velotron cycle ergometer, separated 
the end of the warm-up and beginning of the sprint cycling testing protocol. The subjects then 
completed a total of five, 15-second sprints, each interspersed with two minutes of passive 
recovery. The sprints were performed at the subjects’ maximal cadence against a flywheel 
resistance relative to the subjects’ body mass (0.075 kp per kg body mass). Immediately before 
each 15-second sprint, prior to applying resistance to the flywheel, subjects received three 
seconds to increase the flywheel speed from a standstill, effectively providing a small flying 
start. Verbal encouragement was provided to all participants during each sprint. The Velotron 
cycle ergometer, interfaced with its corresponding Wingate software, measured and recorded 
peak power output and total work performed during each sprint. Upon completing the sprint 
cycling testing procedures, the subjects changed back into their own clothing. 
 Before leaving the pre-supplementation testing session, each subject was provided with a 
copy of the Bouchard Three-Day Physical Activity Record (Bouchard et al., 1983). Subjects 
were also asked to complete a three-day diet record, which required the subjects to record all 
food and drink consumed, during the same three days that they completed the Bouchard Three-
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Day Physical Activity Record. Subjects were asked to complete the Bouchard Three-Day 
Physical Activity Record and a three-day diet record over two week days and one weekend day 
during the supplementation protocol. Subjects returned the Bouchard Three-Day Physical 
Activity Record and three-day diet record to the researchers by email, mail, or in person. 
Information was collected from the three-day diet record and was later entered into Nutritionist 
Pro software to determine daily macronutrient and total energy intake values. The Bouchard 
Three-Day Physical Activity Record was used to estimate daily energy expenditure values. 
 Post-supplementation testing followed identical procedures, as did the pre-
supplementation testing, and was completed within three days of the final day of terminating the 
supplementation intervention.  
  Supplementation protocol. After being randomly placed into either the creatine-
electrolyte or placebo group, and after completing pre-supplementation testing, the subjects were 
provided with their respective supplementation material. Each subject was provided with a 
package containing 42 individually packaged daily doses (i.e. one tablespoon) of his or her 
respective supplementation material, which lasted him or her the duration of the intervention. 
The creatine-electrolyte group consumed four grams of creatine combined with electrolytes (i.e. 
286 mg magnesium chloride, 171 mg calcium chloride, 171 mg potassium chloride, 114 mg 
sodium chloride) per day, while the placebo group consumed a placebo treatment of an equal 
volume of maltodextrin, a commonly used placebo treatment material (Deutekom et al., 2000; 
Green et al., 2001; Izquierdo et al., 2002; Kinugasa et al., 2004). The creatine-electrolyte and 
placebo supplementation materials were matched for appearance by the manufacturer. Subjects 
were instructed to consume each dose orally with approximately 500 ml or 16 fluid oz. of water. 
Subjects were also given a Classic 28 fluid oz. shaker bottle (BlenderBottle Company, Lehi, UT) 
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and 42 sugar and caffeine free instant drink packets, Orange Crush (The Jel Sert Company, West 
Chicago, IL), which they were allowed to mix with their supplementation material for improved 
palatability. If a subject reported missing more than three supplement days, they were dropped 
from the study. The intervention duration was six weeks. Subjects were asked to keep their 
training programs and diets consistent throughout the study. 
Data analysis. Descriptive data is provided as means and standard deviations. Peak 
power output was defined as the maximum 1/10th second average power output identified by the 
Velotron Racer-Mate across any one of the five, 15-second cycling sprints. Total work 
performed is the sum of the work completed during all five, 15-second cycling sprints. Two-way 
mixed model ANOVAs with repeated measures on time (pre- and post-supplementation) were 
used to assess the effects of supplementation (creatine-electrolyte and placebo) on peak power 
output, total work performed, body mass, body composition (i.e. percent body fat, fat mass, fat 
free mass), and body water volumes (i.e. total body, intracellular, and extracellular water 
volumes). Alpha level was set a priori at 0.05. For significant supplement x time interactions, a 
Bonferroni correction was made to the alpha level. In addition, the effect size was calculated as 
partial eta squared. Partial eta squared (ηp2 ) was interpreted in accordance with the guidelines 
provided by Vincent (1999), where, ηp2  > 0.01 was small, ηp2 > 0.06 was medium, and ηp2  > 
0.15 was large. All statistical procedures were performing using SPSS (Version 23).  
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Chapter IV 
Results and Discussion 
Introduction 
 The purpose of this study was to investigate the effects of a six-week creatine and 
electrolyte supplementation intervention on peak power output and total work performed during 
repetitive, short duration sprint cycling performance, in a group of recreational cyclists. The 
design of the study was a randomized double-blind placebo control trial where differences in 
cycling sprint performance (i.e. peak power output and total work) and measurements of body 
mass, composition, and water volume were examined pre- and post-six-week supplementation 
with either creatine and electrolytes or placebo materials. In this section, the results of the 
subjects’ demographics, and the primary (i.e. peak power output and total work) and secondary 
(i.e. body mass, composition, and water volume) dependent variables are presented.   
Subject Demographics 
 Thirty-eight apparently healthy recreational cyclists, between the ages of 19 – 33 years, 
who rode a bicycle at least twice per week in the past six months, were recruited for this study. 
Nineteen subjects completed pre-supplementation testing for both the creatine-electrolyte and 
placebo groups. Three subjects, two males and one female, did not complete post-
supplementation testing and were dropped from the study. One of the male participants 
terminated participation due to gastrointestinal discomfort from taking the supplement. The other 
male participant sustained a knee injury (unrelated to the study) and was not able to complete 
post- supplementation testing. The female subject was dropped because she stopped taking the 
supplement. The final subject pool consisted of 35 recreational cyclists, 17 in the creatine-
electrolyte group, and 18 in the placebo group. Only data from subjects who completed pre- and 
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post-supplementation testing were included in data analysis. The demographics of the subjects 
who completed pre- and post-supplementation testing are presented in Table 1.  
 
 Placebo Creatine-Electrolyte 
 PRE POST PRE POST 
Age (yr) 23.6 ± 3.4 23.7 ± 3.4 23.4 ± 4.0 23.5 ± 4.0 
Height (m) 1.75 ± 0.09 1.76 ± 0.09 1.72 ± 0.07 1.72 ± 0.07 
Mass (kg) 70.4 ± 10.4 69.8 ± 9.6 69.6 ± 7.4 71.0 ± 7.6* 
Sex 11 Males / 7 Females 12 Males / 5 Females 
Table 1. Subject demographics, including: age, height, mass, and sex (n = 35) (mean ± SD); * 
significant (p<0.05, ηp2 = 0.312) difference from pre-supplementation testing. 
For the total work data two subjects (one in each group) were unable to finish all five 
sprints during pre-testing. These participants did complete all other testing procedures and four 
sprints at pre- and post-supplementation testing. Their data were not included in the analysis of 
total work. Only 15 subjects in the placebo group, and 14 subjects in the creatine-electrolyte 
group submitted a Bouchard Three-Day Physical Activity Record and three-day diet record. 
Therefore, daily expenditure, dietary macronutrient and total energy intake values were 
calculated with only these subjects’ data.  
Results of the Study 
 After six weeks of supplementation, significant time x supplementation interactions were 
observed for peak power (F1,33 = 5.521, p = 0.025, ηp2 = 0.143) and total work performed (F1,31 = 
5.740, p = 0.023, ηp2 = 0.156). Statistical analysis revealed medium and large effect sizes for the 
improvements in peak power output and total work performed, respectively. Post-hoc 
comparisons revealed that at pre-supplement testing there were no significant differences in peak 
power output or total work performed between the creatine-electrolyte and placebo groups. From 
pre- to post-supplementation testing, there were significant increases in peak power output and 
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total work performed during the five, 15-second sprints when supplemented with creatine and 
electrolytes, but not when supplemented with the placebo treatment. Peak power output during 
the five, 15-second sprints increased by ~ 4% (~ 27 W; p<0.001) for the creatine-electrolyte 
group, compared to ~ 1% (~ 5 W; p=0.459) for the placebo group. Similarly, total work 
performed over the five, 15-second sprints increased by ~ 5% (~ 1,862 J; p<0.001) for the 
creatine-electrolyte group compared to ~ 2% (~ 580 J; p=0.130) for the placebo group. The peak 
power output and total work data are presented in Table 2.  
 
 Placebo Creatine-Electrolyte 
 PRE POST PRE POST 
Peak Power Output (W) 668.7 ± 152.0 673.6 ± 155.1 671.8 ± 123.0 698.4 ± 124.4* 
Total Work (J) 42284.4 ± 9345.5 42864.8 ± 9606.8 40607.2 ± 7780.9 42469.6 ± 8135.6* 
Table 2. Pre- and post-supplementation peak power output (n = 35) and total work performed (n 
= 33) during the five, 15-second cycling sprints, interspersed with two minutes of passive 
recovery, for the placebo and creatine-electrolyte groups (mean ± SD); * significant (p<0.05) 
difference from pre-supplementation testing. 
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Figure 1. Peak power output (W) achieved during the five, 15 second sprints, during pre- and 
post-supplementation testing, in the placebo and creatine-electrolyte groups.  
 
Figure 2. Total work (J) performed during the five, 15 second sprints, during pre- and post-
supplementation testing, in the placebo and creatine-electrolyte groups. 
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Figure 3. Pre- and post-supplementation ensemble power output curves for the placebo and 
creatine-electrolyte groups. The ensemble power output curves were compiled by averaging the 
power output curves of the one, 15-second sprint in which the subjects’ peak power outputs were 
achieved. 
 For total body mass (F1,33 = 14.979, p<0.001, ηp2 = 0.312) and fat free mass (F1,33 = 
14.164, p=0.001, ηp2 = 0.300), time x supplement interactions were also observed. Statistical 
analysis revealed large effect sizes for the increases in total body mass and fat free mass. Post-
hoc comparisons with a Bonferroni correction showed that the magnitudes of these variables 
significantly increased for the creatine-electrolyte group but not the placebo. For the creatine-
electrolyte group, body mass was significantly increased by ~ 2% (1.3 kg; p=0.001) from pre- to 
post-supplementation testing. Similarly, fat free mass significantly increased by ~ 2% (1.4 kg; 
p<0.001) from pre- to post-supplementation testing. There were no significant changes in total 
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body mass (p=0.088) and fat free mass (p=0.949) in the placebo group from pre- to post-
supplementation testing. In addition, there were no significant differences in percent body fat and 
fat mass for either group from pre- to post-supplementation testing. All body composition data 
are presented in Table 3. 
 Placebo Creatine-Electrolyte 
 PRE POST PRE POST 
 Body Mass (kg) 70.4 ± 10.4 69.8 ± 9.6 69.6 ± 7.4 71.0 ± 7.6* 
Percent Body Fat (%) 13.6 ± 8.6 12.9 ± 8.5 11.7 ± 8.6 11.4 ± 9.0 
Fat Mass (kg) 9.4 ± 5.9 8.8 ± 5.5 8.1 ± 6.2 8.1 ± 6.6 
Fat Free Mass (kg) 61.0 ± 11.7 61.0 ± 11.6 61.5 ± 9.1 62.9 ± 9.3* 
Table 3. Pre- and post-supplementation body mass, body composition, fat mass, and fat free 
mass (mean ± SD) (n = 35); * significant (p<0.05) difference from pre-supplementation testing. 
For the creatine-electrolyte group, a modest, but significant, association (r = 0.626; p = 
0.007) was observed between the increases in peak power output and fat free mass from pre- to 
post-supplementation testing. 
There were no significant differences in any of the body water variables between the 
creatine-electrolyte and placebo groups at pre-testing. For total body and intracellular water 
volumes, no significant differences were observed from pre- to post-supplementation testing. 
However, a small (0.3-0.5 L), but significant (F1,33 = 4.729, p=0.037, ηp2 = 0.125) reduction in 
extracellular water volume were observed from pre- to post-supplementation testing for both 
groups. Statistical analysis revealed a medium effect size for the decrease in extracellular body 
water. Body water data is presented in Table 4. 
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 Placebo Creatine-Electrolyte 
 PRE POST PRE POST 
Total Body Water (L) 41.5 ± 7.9 40.3 ± 7.4 40.0 ± 6.5 39.9 ± 6.6 
Intracellular Water (L) 23.6 ± 5.1 22.9 ± 4.9 22.7 ± 4.4 22.8 ± 4.5 
Extracellular Water (L) 17.9 ± 3.0 17.4 ± 2.7* 17.3 ± 2.4 17.1 ± 2.2* 
Table 4. Pre- and post-supplementation total body, intracellular, and extracellular water volume 
for the placebo and creatine-electrolyte groups (mean ± SD) (n = 35); * significant (p<0.05) 
difference from pre-supplementation testing. 
 
 Three subjects in the placebo group and two subjects in the creatine-electrolyte group did 
not submit Bouchard Three-Day Physical Activity and three-day diet records. One subject in the 
creatine-electrolyte group submitted a three-day diet log, but not a Bouchard Three-Day Physical 
Activity Record. Therefore, the dietary intake values presented in Table 5 come from 15 subjects 
in the placebo group, and 14 subjects in the creatine-electrolyte group, while the energy 
expenditure values come from 15 subjects in the placebo group, and 13 subjects in the creatine-
electrolyte group. There were no significant differences in any dietary intake or energy 
expenditure variable between groups. The energy expenditure and dietary intake values are 
presented in Table 5.  
 
 Placebo Creatine-Electrolyte 
Energy Expended (Kcal.d-1) 3226.7 ± 590.3 3287.1 ± 526.3 
Dietary Energy Intake (Kcal.d-1) 2408.7 ± 709.9 2447.5 ± 880.8 
Dietary Carbohydrate (g.d-1) 261.4 ± 83.4 277.0 ± 114.2 
Dietary Fat (g.d-1) 108.9 ± 41.1 96.4 ± 33.7 
Dietary Protein (g.d-1) 95.9 ± 25.0 118.1 ± 54.1 
Table 5. Dietary intake (n = 29) and energy expenditure (n = 28) values (mean ± SD).  
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Discussion  
 The primary purpose of this study was to investigate the effects of six weeks of creatine 
and electrolyte supplementation on peak power output and total work performed during 
repetitive, short duration sprint cycling performance, in a group of recreational cyclists. 
Additionally, pre- to post-supplementation changes in body mass, body composition (i.e. percent 
body fat, fat mass, and fat free mass), and body water (i.e. total body, intracellular, and 
extracellular water volume) were investigated. It was hypothesized that creatine-electrolyte 
supplementation would result in significant improvements in peak power output and total work 
performed during five, 15-second cycling sprints, interspersed with two minutes of passive 
recovery. It was also hypothesized that creatine-electrolyte supplementation would result in 
significant increases in total body mass, fat free mass, and body water (i.e. total body, 
intracellular, and extracellular water volume). Results of the present study support the primary 
hypothesis that creatine and electrolyte supplementation lead to significant increases in peak 
power output and total work performed during five, 15-second cycling sprints. This hypothesis is 
supported by results of both performance variables. A 4% (~ 27 W) increase in peak power 
output (p<0.05), and a 5% (~ 1,862 J) increase in total work performed (p<0.05) were observed 
from pre- to post-supplementation for the creatine-electrolyte group but not the placebo group. 
 The peak power output observed for the subjects included in this study, regardless of 
group identification and testing time, was 678 ± 137 watts. This value is similar to, however, 
lower than the peak power outputs reported in previous studies investigating peak power output 
during sprint cycling, each reporting peak power output values ranging between 700 – 850 watts 
(Birch et al., 1994; Lopez et al., 2014; Okudan & Gokbel, 2005; Smith & Hill, 1991; 
Tarnopolsky & MacLennan, 2000). Making meaningful comparisons between the absolute 
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magnitude of the peak power outputs achieved by the subjects in the present study and those of 
previous studies is difficult, as peak power output is influenced by many factors, including: the 
type of cycle ergometer used to measure power output (Abbiss et al., 2009; Astorino & Cottrell, 
2012), the magnitude of the resistive load applied to the flywheel (Dotan & Bar-Or, 1983; 
Vandewalle et al., 1985), starting technique (Clark, 2015; Robergs et al., 2015), and sprint 
cycling posture (Millet et al., 2002; Reiser et al., 2002). Therefore, Abbiss et al. (2009) caution 
researchers about making comparisons between the absolute magnitudes of reported power 
output values of previous sprint cycling studies. 
 The ~ 4% (~ 27 W) increase in peak power output observed in the present study, post-
creatine-electrolyte supplementation, was statistically significant (p<0.05). This is the first time 
significant improvements in peak power output during sprint cycling have been reported 
following creatine-electrolyte supplementation. Previous studies investigating the efficacy of 
creatine-electrolyte supplementation to improve sprint cycling performance have not reported 
significant increases in peak power output (Finn et al., 2001; Kreider et al., 1998). Following five 
days of creatine-electrolyte supplementation, Finn et al. (2001) report a trend toward significant 
improvements in peak power output during the first one of four 20-second cycling sprints. 
During no other sprint was there a trend toward significantly improved peak power output (Finn 
et al., 2001). It is important to consider that the supplementation protocol used in the study by 
Finn et al. (2001) was a creatine-electrolyte loading supplementation protocol, lasting only five 
days. Therefore, with such a short-duration supplementation intervention, increases in peak 
power output would primarily rely on increases in intramuscular phosphocreatine content, and 
not increased protein synthesis (Abe et al., 2000; DeFreitas et al., 2011; Preen et al., 2001). 
Muscle biopsies taken pre- and post-creatine-electrolyte supplementation in the study by Finn et 
  	
 
44	
al. (2001) demonstrated no significant increase in intramuscular phosphocreatine content. Since 
the intramuscular phosphocreatine content of muscle biopsies were not significantly different, it 
is not surprising that the subjects in the study by Finn et al. (2001) did not increase their peak 
power outputs following only five days of supplementation. Furthermore, Finn et al. (2001) do 
not report pre- and post-supplementation peak power output values. Similarly, Kreider et al. 
(1998) make no mention of changes in peak power output after supplementing their subjects with 
a creatine-electrolyte material for 28 days, and do not report peak power output values. 
Therefore, it is not possible to compare the percent change in peak power output observed in the 
present study with results of the studies by Finn et al. (2001) and Kreider et al. (1998). 
 However, the ~ 4% increase in peak power output observed in the present study is 
comparable with results of previous studies reporting significant increases in peak power output 
of about 3 – 5% during sprint cycling, post-creatine supplementation (Ahmun, Tong, & 
Grimshaw, 2005; Dawson et al., 1995; Preen et al., 2001; Tarnopolsky & MacLennan, 2000). 
Some studies have reported greater post-creatine supplementation improvements in peak power 
output, ranging between 7 – 9% (Birch et al., 1994; Vandebuerie et al., 1998; Wiroth et al., 
2001). However, while the present study used male and female subjects, in the studies by Birch 
et al. (1994), Vandebuerie et al. (1998), and Wiroth et al. (2001) subjects were all young males. 
Having only male subjects may lead to greater percent improvements in peak power output, as 
males tend to have greater proportions of type II muscle fibers (Haizlip, Harrison, & Leinwand, 
2015), and having greater proportions of type II muscle fibers typically leads to an increased 
ergogenic response to creatine supplementation (Syrotuik & Bell, 2004). 
 The total work performed across the five 15-second sprints by the subjects included in 
this study, regardless of group identification and testing time, was 42,057 ± 8,614 joules. No 
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other studies report total work values when the subjects completed five 15-second sprints 
interspersed with two minutes of passive recovery. Cooke et al. (1995) report their subjects 
performed about 11,285 joules of total work during a 15-second cycling sprint. Unlike the 
present study, which included male and female subjects, the subjects in the study by Cooke et al. 
(1995) were all males. The male subjects participating in the current study, regardless of group 
identification, testing time, or the successful completion of the fifth sprint, averaged 10,176 ± 
1,325 joules of total work performed during the first 15-second sprint. This value is still lower 
than the total work performed by the subjects in the study by Cooke et al. (1995). However, male 
subjects in the current study performing a magnitude of total work within one standard deviation 
above of the average could meet or exceed the average total work performed by the subjects in 
the study by Cooke et al. (1995). It is important to note that while the present study used a 
Velotron cycle ergometer to measure work done, Cooke et al. (1995) used a Monark cycle 
ergometer. Astorino and Cottrell (2012) report, when all other sprinting protocol variables are 
held constant, mean power outputs are greater when measured on a Monark versus Velotron 
cycle ergometer. Therefore, total work performed will be greater when measured on a Monark 
versus Velotron cycle ergometer. The small discrepancy between the magnitudes of total work 
performed during a single 15-second sprint by subjects in the study by Cooke et al. (1995) and 
male subjects in the present study may be explained by the inter-study cycle ergometer variations 
and the training status of the subjects. 
 The ~ 5% (~ 1,862 J) increase in total work performed during sprint cycling observed in 
the present study was statistically significant (p<0.05). Previous research has reported mixed 
results with respect to post-creatine-electrolyte supplementation changes in total work performed 
(or mean power) during sprint cycling (Finn et al., 2001; Kreider et al., 1998). While subjects in 
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the study by Finn et al. (2001) demonstrated a trend toward significantly improved mean power 
output (comparable to total work) during the first of four 20-second cycling sprints, each 
interspersed with 20-seconds of recovery, during no other sprint effort was there a trend toward 
significantly improved mean power output. It is likely that the relatively long duration (20 
seconds) of the sprints used in the study by Finn et al. (2001) would lead to extensive 
intramuscular phosphocreatine depletion, and rely more heavily on other energy systems to meet 
the energy demands of the sprint (Smith & Hill, 1991). Furthermore, recovery durations of only 
20-seconds would not allow for adequate intramuscular phosphocreatine resynthesis (Greenhaff 
et al., 1994). It is intuitive that the mean power outputs were not significantly improved during 
the first or subsequent sprint bouts in the study by Finn et al. (2001). 
 Kreider et al. (1998), however, report significant increases in the total amount of work 
performed, per sprint, for the first five of 12 six-second sprints. Following 28 days of creatine-
electrolyte supplementation, subjects in the study by Kreider et al. (1998) increased the total 
amount of work they performed during the initial five of 12 six-second sprints, by about 10 – 
15% per sprint. From sprints six through 12, however, the increases in total work performed 
were not significantly different from the increases in total work performed following the placebo 
treatment (Kreider et al., 1998). Unfortunately, it is difficult to make comparisons between the 
percent increases in total work performed reported by Kreider et al. (1998) with the percent 
increase in total work performed observed in the present study. While the present study utilized 
15-second cycling sprints, the study by Kreider et al. (1998) used six-second cycling sprints. As 
the phosphagen system has a limited capacity to contribute energy turnover at a high degree, the 
phosphagen system would be able to provide an overall greater relative amount of the energy 
turnover during a six-second cycling sprint compared to 15-second cycling sprint (Gaitanos et 
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al., 1993; Smith & Hill, 1991). Furthermore, Kreider et al. (1998) report changes in total work 
performed per sprint, while the present study reports the change in the total work performed 
across all five 15-second sprint efforts. The ~ 5% increase in total work performed in this study 
is comparable with results of previous studies reporting 5 – 6% increases in total work performed 
during cycling sprint testing (Birch et al., 1994; Preen et al., 2001; Wiroth et al., 2001).  
  The secondary hypothesis of this study stated that creatine-electrolyte supplementation 
would result in significant increases in total body mass, fat free mass, and body water. Results of 
the present study partially support the secondary hypothesis. The ~ 2% (1.3 kg) increase in total 
body mass from pre- to post-supplementation testing was statistically significant (p<0.05) in the 
creatine-electrolyte group. Similarly, the ~ 2% (1.4 kg) increases in fat free mass from pre- to 
post-supplementation testing reached statistical significance (p<0.05) in the creatine-electrolyte 
group. For the placebo group, changes in total body mass and fat free mass were not statistically 
different from pre- to post-supplementation testing. Also, there were no significant pre- to post-
supplementation changes in total body and intercellular water in either group. There were 
significant decreases in the extracellular water in the creatine-electrolyte (~ 1%) and placebo (~ 
3%) groups from pre- to post-supplementation testing.   
 The ~ 2% (1.3 kg) increase in total body mass from pre- to post-supplementation testing 
for the creatine-electrolyte group is similar to the results of previous research reporting 
significant post-creatine-electrolyte supplementation increases in total body mass, ranging 
between about 1 – 2% (0.8 – 2.2 kg) (Finn et al., 2001; Kreider et al., 1998). Following five days 
of creatine-electrolyte supplementation, Finn et al. (2001) report a small (0.81 kg, ~ 1.1%) but 
significant increase in total body mass. Following 28 days of creatine-electrolyte 
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supplementation, Kreider et al. (1998) reported greater increases in total body mass (2.2 kg, ~ 
2.4%).  
 The  ~ 2% (1.4 kg) increase in fat free mass from pre- to post-supplementation testing 
reached statistical significance (p<0.05) in the creatine-electrolyte group. Previous studies 
investigating changes in fat free mass post-creatine-electrolyte supplementation have reported 
similar, but greater (2.4 – 3.2 kg, 3.4 – 4.6%) increases in fat free mass following 28 days 
(Kreider et al., 1998) and eight weeks (Stout et al., 1999). However, subjects in the studies by 
Kreider et al. (1998) and Stout et al. (1999) participated in structured whole-body resistance 
training programs aimed at increasing muscular strength and hypertrophy during their 
supplementation interventions. The subjects in the present study continued performing regular 
recreational activites. Resistance training stimulates multiple cellular pathways, including ones 
driven by cellular swelling (i.e. cellular hydration), leading to increased protein synthesis and 
muscle hypertrophy (Haussinger, 1996; Schoenfeld, 2010). Additionally, upper body muscle 
hypertrophy preceeeds lower body muscle hypertrophy (Schoenfeld, 2010). Therefore, 
differences in training types between the subjects in the present study and those in the studies by 
Kreider et al. (1998) and Stout et al. (1999) likely contribute to the observed inter-study 
variations in the percent increases in fat free mass (Schoenfeld, 2010).  
 Part of the secondary hypothesis stated that creatine-electrolyte supplementation would 
lead to significant increases in body water (i.e. total body, intracellular, and extracellular water). 
Results of the pre- to post-supplementation changes in body water in the present study do not 
support this hypothesis. There were no significant differences between total body and 
intracellular water in the placebo and creatine-electrolyte groups. There were, however, 
significant (p<0.05) decreases in the extracellular water of both the creatine-electrolyte and 
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placebo groups. There was no difference between the post-supplementation decreases in body 
water between the groups. Since it was hypothesized that body water would increase following 
creatine-electrolyte supplementation, the results of the body water analysis in the present study 
were unexpected. It was hypothesized total body water would be increased post creatine-
electrolyte supplementation, due to the osmotic effect of creatine, and previous research 
reporting significant increases in total body water (Powers et al., 2003). In the study by Powers 
et al. (2003), a seven-day creatine loading protocol resulted in significant increases in total body, 
intracellular, and extracellular water of 3.3%, 3.9%, and 2.4% of pre-supplementation values, 
respectively. In the same study, following an additional 21-day creatine maintenance 
supplementation period, total body, intracellular, and extracellular water were further increased 
to 4.9% and 4.6%, and 5.4% of pre-supplementation values, respectively. However, results of the 
study by Kreider et al. (1998) and the present study are inconsistent with the findings of Powers 
et al. (2003). After 28 days of creatine-electrolyte supplementation, Kreider et al. (1998) report 
no significant changes in total body water. The results of the present study are in line with the 
results of Kreider et al. (1998), as it was found that six-weeks of creatine-electrolyte 
supplementation did not lead to significant changes in total body and intracellular water. 
 Numerous previous studies utilizing creatine-loading protocols lasting less than one week 
in duration have reported significant increases in body mass ranging between 1 – 3% (Birch et 
al., 1994; Cottrell et al., 2002; Deutekom et al., 2000; Finn et al., 2001; Kinugasa et al., 2004; 
Preen et al., 2001; Snow et al., 1998; Yquel et al., 2002; Ziegenfuss et al., 2002). It is likely that 
these early increases in body mass are due to increased body water retention (Powers et al., 2003; 
Turjung et al., 2000). Harris et al. (1992) report the greatest increases in intramusclular creatine 
content is within the first two days of intiating a creatine-loading supplementaion protocol, with 
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further increases in intramusclular creatine content greatly slowing and plateauing shortly 
thereafter. Ziegenfuss et al. (2002) report a significant increase in body mass (0.9 kg, 1.3%) 
following only three days of creatine supplementation. It is possible that the initial increase in 
intramuscular creatine content is accompanied by an increase in body water (i.e. intracellular and 
extracellular water), as reported by Powers et al. (2003), leading to increases in body mass. 
Furthermore, it may be possible that early increases in total body water (i.e. intracellular and 
extracellular water) lead to increased cullular hydration (i.e. cellular swelling), stimulating 
myosin protein synthesis, contributing to increases in fat free mass with sustained 
supplementaion (Haussinger, 1996; Powers et al., 2003; Schoenfeld, 2010). By only measuring 
body composition and body water pre- and post-six weeks of creatine-electrolyte 
supplementation, it is possible that early changes in body water were missed. Whether or not 
increased cellular hydration occurred early in the supplementation protocol, thus contributing to 
the significant increase in fat free mass in the present study, remains unknown.  
 There was a modest but significant (r = 0.626; p = 0.007) association between the pre- to 
post-supplementation increases in peak power output and fat free mass observed in the present 
study. This association suggests that the performance enhancement elicited by creatine-
electrolyte supplementation may not soley due to increases in intramuscuclar creatine and 
phosphocreatine contents, but may also be in part due to the increase in fat free mass resulting 
from supplementation. Previous studies have reported creatine supplementaion to lead to 
increased myosin heavy chain production (i.e. protein synthesis) (Ingwall, Morales, & Stockdale, 
1972; Ingwall, Weiner, Morales, Davis, & Stockdale, 1974). Since significant increases in 
protein synthesis take longer than one week to occur (DeFreitas et al., 2011), it is likely that the 
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effictivness of creatine-electrolyte supplementaion protocols would increase with sustained 
supplementation. 
Summary 
 Results of the present study indicate that six weeks of creatine and electrolyte 
supplementation leads to significant increases in peak power output and total work performed 
during repetitive sprint cycling; as well as significant increases in body mass and fat free mass.  
The significant increase in peak power output observed in this study is the first time a significant 
increase in peak power output has been observed following creatine-electrolyte supplementation. 
The post creatine-electrolyte supplementation improvements in sprint cycling performance (i.e. 
peak power output and total work performed) observed in the present study are consistent with 
previous studies investigating changes in peak power and total work performed during sprint 
cycling post-creatine supplementation (Ahmun, Tong, & Grimshaw, 2005; Birch et al., 1994; 
Dawson et al., 1995; Preen et al., 2001; Tarnopolsky & MacLennan, 2000; Wiroth et al., 2001). 
The significant increases in body mass and fat free mass observed in the present study are also 
consistent with previous studies investigating changes in body mass and fat free mass, post-
creatine supplementation (Kreider et al., 1998; Preen et al., 2001; Stout et al., 1999). There were 
no significant pre- to post-supplementation changes in total body and intracellular water. There 
were significant pre- to post-supplementation decreases in the extracellular water of the creatine-
electrolyte and placebo supplementation groups.  
 These results suggest that recreational cyclists wanting to increase their peak power 
output and total work performed during repetitve sprint cycling performaces may benefit from 
participating in a creatine-electrolyte supplementation protocol similar to the one used in the 
present study. Furthermore, results of this study suggest that increases in fat free mass are 
  	
 
52	
associated with improved sprint cycling performance. For the creatine-electrolyte group, a 
modest but significant association (r = 0.626; p = 0.007) was observed between the increases in 
peak power output and fat free mass. These results indicate that physiological mechanisms 
beyond increased intramuscular total creatine content contributes to the ergogenic effect of 
creatine-electrolyte supplementation. 
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Chapter V 
Summary and Conclusions 
Summary 
 Creatine supplementation is commonly recommended for individuals looking to increase 
power production during short duration, high-intensity activities, such as sprint cycling (Mesa et 
al., 2002; Turjung et al., 2000). Many studies investigating the efficacy of creatine 
supplementation on sprint cycling performance utilize creatine-loading protocols, with 
supplementation interventions lasting less than or equal to one week (Ahmun et al., 2005; 
Cottrell et al., 2002; Finn et al., 2001; Kinugasa et al., 2004; Okudan & Gokbel, 2005; Snow et 
al., 1998; Wiroth et al., 2001; Ziegenfuss et al., 2002). These studies are primarily assessing the 
effectiveness of creatine supplementation to provide ergogenic effects via increased 
intramuscular creatine and phosphocreatine contents. However, longer duration supplementation 
with a creatine-electrolyte supplementation material has been reported to significantly increase 
fat free mass (Kreider et al., 1998; Stout et al., 1999). 
 In the present study, six weeks of creatine-electrolyte supplementation lead to significant 
increases in peak power output and total work performed during repetitive sprint cycling. The 
results of the present study demonstrate that there is an association between the post creatine-
electrolyte supplementation increases in peak power output and fat free mass. Therefore, in 
addition to increases in intramuscular creatine and phosphocreatine contents, creatine 
supplementation elicits its ergogenic effect via increasing fat free mass. The time course of these 
changes remains unclear. 
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Conclusions 
 Six weeks of creatine-electrolyte supplementation leads to significantly increased peak 
power output and total work performed during repetitive sprint cycling performance. Aditionally, 
six weeks of creatine-electrolyte supplementation leads to a significant increase in body mass. 
The increase in body mass is attributed to the increase in fat free mass, but not increases in body 
water. A modest postive association was observed between increases in peak power generated 
and fat free mass post creatine-electrolyte supplementation.  
Recommendations 
 The following recommendations are suggested for further investigations: 
1. In order to investigate the underlying mechanisms involved with changes in body mass, 
composition, and body water, future research should conduct a similar creatine-electrolyte 
supplementation intervention, while assessing changes in these variables earlier in the 
intervention, and more often. 
2. Future research should test the efficacy of the same supplementation protocol at improving 
other short duration, high-intensity activities. Since the significant increase in peak power output 
observed in the present study was associated with an increase in fat free mass, and upper body 
hypertrophy precedes lower body hypertrophy, testing the same supplementation protocol in a 
group of recreational level upper body power athletes (e.g. rowers, and throwers) would be 
interesting. 
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Western Washington University 
Health and Human Development Department 
 
Consent to Take Part in a Research Study 
 
Project: Effect of a Multi-ingredient Performance Supplement (MIPS) on Sprint 
Cycling Performance. 
	
You are invited to participate in a study investigating the effects of a multi-ingredient 
performance supplement (MIPS), containing creatine and electrolytes (like those in a sports 
drink), on sprint cycling performance pre- and post- a supplementation intervention with either 
placebo or MIPS. To improve upon past studies, this analysis aims to objectively evaluate a 
soluble creatine supplement versus placebo on sprint cycling performance in an athletic 
population. The results of this study will enhance our understanding of this supplement and how 
it may affect physical performance.   
I UNDERSTAND THAT: 
 
1. This experiment will begin with measurements of height, weight, body composition with 
skinfold calipers, and body water determination using a bio-electrical impedance unit. 
Height will be measured with a stadiometer and weight with a balance beam scale. Body 
composition assessment will be completed using skinfold measurements taken at three 
anatomical locations. The three sites used for male subjects will be on the chest, 
abdomen, and thigh. Female subjects will have skinfold measurements taken on the back 
of the arm, over the hip, and thigh. For determining total body water, an impedance 
device is used. For this test, you will lie on a table and have electrodes attached to your 
right wrist and ankle. It takes less than a minute, and then the electrodes are removed. My 
participation for these tests will be approximately 30 minutes. Height, weight, total body 
water, and body composition will be determined during pre- and post-testing. 
 
2. Both groups will undergo pre- and post-supplementation testing sessions to assess sprint 
cycling performance (i.e. peak power output and total work performed). During the sprint 
cycling tests, subjects will complete five, 15-second sprints, interspersed with two 
minutes of passive recovery on a Velotron cycle ergometer equipped with instrumented 
bicycle pedals. The resistance applied will be relative to the subject’s body mass, and the 
subjects will be asked to pedal at their maximal cadence. The subjects will be verbally 
encouraged to put forth maximal effort during all sprints. Data collected during the sprint 
cycling testing will be entered into I-Crankset software in order to determine peak power 
output and total work performed. 
3. Supplementation will be either treatment (creatine and electrolytes, like those in a sports 
drink) or placebo (sugar) for 6 weeks in a blinded fashion. Blinded is that neither the 
subject nor the researcher providing the numbered supplement will know whether the 
supplement is the treatment or placebo until the end of the 6-week period. The randomly 
assigned supplementation material will be provided at pre-testing. For this study, 
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consistent dietary and exercise programs should be maintained. During the first week of 
supplementation, I will keep a 3-day diet record and 3-day physical activity record that 
will be submitted for analysis. 
 
4. I understand that exercise can lead to muscular soreness, cramping, pain, and fatigue. 
During testing, there is a risk of experiencing muscle soreness that should disappear after 
a period of rest. I understand that if exercise testing is painful, I can stop at any time. In 
addition, I am aware that I could experience delayed onset muscle soreness (DOMS) after 
the session that could last for 24-72 hours. The safeguards that will be used minimize 
potential muscle soreness include a warm-up, acclimation, and cool down period. If I feel 
like I cannot or should not perform any of these tasks, I could opt out from the 
participation in this study. 
 
5. Possible benefits include that subjects may be have performance benefits associated with 
supplementation. The results of this study may aid in future research.  
 
6. There is twenty dollars ($20) compensation for my participation in the complete project: 
supplementation, pre- and post-testing. My participation is voluntary, I may choose to 
withdraw my consent and discontinue participation without penalty.  
 
7. All information collected is confidential. My signed consent form will be kept in a locked 
cabinet separate from the data collection forms for the project data. My name will not be 
associated with any of my data collected throughout the study. 
 
8. My signature on this form does not waive my legal rights of protection. 
 
9. Any questions you may have regarding the study procedures will be answered by the 
primary researchers (Harsh Buddhadev, Daniel Crisafulli) who can be contacted at 
Harsh.Buddhadev@wwu.edu  (360-650-4115) or crisafd@students.wwu.edu (360-650-
2851).  Any questions about your rights as a research subject should be directed to Janai 
Symons, the WWU Research Compliance Officer (RCO), 360-650-3082.  If any injury or 
adverse effect of this research is experienced you should contact Harsh Buddhadev, 
Daniel Crisafulli, or the RCO. 
 
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦
♦♦♦♦♦ 
I have read the above descriptions and agree to participate in this study. 
 
_______________________________________   _____________________ 
Participant’s Signature      Date 
 
_______________________________________ 
Participant’s PRINTED NAME 
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Human Subjects Activity Review 
 
1. What is your research question, or the specific hypothesis? 
  Supplementation with creatine is recommended for athletes looking to improve power 
output during short duration, high intensity activities, such as sprinting on a cycle. However, 
previous studies investigating the effect of creatine supplementation on parameters of sprint 
cycling have demonstrated inconsistent results. This study will investigate the efficacy of a 
creatine and electrolyte (MIPS) supplementation on peak power output and total work 
performed during five, 15-second sprint efforts of a cycle ergometer. The primary null 
hypothesis states that, when compared to placebo treatment, the multi-ingredient supplement 
(creatine and electrolyte) will not result in improvements in peak power output and total 
work performed during repetitive, short duration sprint cycling performance in trained 
cyclists. The secondary hypothesis is that the multi-ingredient supplement will not result in 
increased water retention or a significant change in body composition compared to placebo 
condition.  
2. What are the potential benefits of the proposed research to the field? 
  Fifty years ago, Gatorade, an original multi-ingredient performance supplement was 
developed, a combination of carbohydrate and electrolytes. The standard sports drinks 
contain 4–8% carbohydrate, 10–30 mmol/L sodium, and 3–5 mmol/L potassium [1]. Other 
electrolytes or protein may also be included in sports drinks formulations. Sports drinks were 
the original prototype of multi-ingredient performance supplements (MIPS). Much recent 
research has been reported with various combinations of MIPS, complex mixes of nutrients 
with the common factor being creatine [2-8]. 
 
  One of the most popular and widely researched natural supplements is creatine, which has 
been extensively studied since the 1990’s for performance enhancement and has been quite 
well supported. Creatine has been assigned group A level of supporting evidence by the 
Australian Institute of Sport [1]. Many aspects of creatine supplementation have been 
reported [9-24]. Increases in body weight, both lean body mass [9- 13, 15, 17, 18] and body 
water [17, 21], are common findings. Training and supplementation elicits improvements in 
muscle strength [9, 11, 12, 14-17, 19, 23] and power [13-17, 20]. When effect size was 
calculated in a meta-analysis on creatine supplementation, there were greater effects for 
upper body, repetitive-bout laboratory-based exercise tasks lasting < 30 seconds versus lower 
body, single-bout, field studies, or longer duration physical activity [10]. There were no 
effects between males and females nor training status.  
 
  The benefits of creatine supplementation are well documented, particularly during repeated 
bouts of high-intensity muscular activity. However, most research evaluating the effects of 
creatine involves use of Wingate testing for determining anaerobic peak and mean power 
plus rate of fatigue [25-33]. The Wingate test shows mixed results in response to short-term 
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creatine supplementation, but is mostly positive, especially in rate of fatigue and repeated 
bouts. It has been suggested that the mixed results may be an artifact due to not accounting 
for flywheel inertia [28]. When corrected, non-significant results became statistically 
significant. Some research has observed outcomes with graded exercise testing, including 
maximal oxygen consumption and anaerobic threshold [34-39]. The main outcomes were no 
changes in maximal oxygen consumption. However, creatine supplementation can alter the 
contributions of the different metabolic systems. Thus, the body is able to perform the sub-
maximal workloads at a lower oxygen cost with a concomitant reduction in the work 
performed by the cardiovascular system. Ventilatory anaerobic threshold does show 
improvement [35, 38, 39]. Newer technology may allow assessment of cycling propulsive 
power. Instrumented bicycle pedals for dynamic measurement of propulsive cycling loads are 
available that may give the sensitivity necessary to determine changes in power [40-42]. 
 
  The mechanism best supporting creatine effects is the increased intramuscular creatine 
concentration and restoration. The ergogenic effect is related to an increase in temporal and 
spatial buffering of ATP and to increased muscle buffer capacity [24]. Different formulations 
of creatine supplementation have been studied, with no appreciable differences in outcomes 
[15-17]. Recently, formulations have been developed to improve aqueous solubility, 
gastrointestinal permeability, and ultimately the outcomes associated with creatine [43]. 
Permeability was improved across Caco-2 human epithelial cell monolayers. This type of 
formulation has potential for improved oral absorption of creatine, and may enhance 
bioavailability, and therefore performance outcomes. 
 
  The purpose of this project is to assess performance outcomes in response to six weeks of a 
multi-ingredient performance supplement, which includes creatine and electrolytes. This 
study elucidates performance enhancements post-creatine and electrolyte supplementation, 
when confounding factors are controlled. These factors are: 1) duration of cycling sprints and 
rest intervals; 2) accounting for flywheel inertia, and; 3) composition of the supplementation 
material. This study also adds to the literature with regards to the ergogenic effect of creatine 
and electrolyte supplementation on sprint cycling performance by providing results with 
respect to peak power output and total work performed during repetitive, short duration sprint 
cycling performance, following a six-week supplementation period in trained cyclists. 
Additionally, body composition and total body water will be appraised. 
 
3. What are the potential benefits, if any, of the proposed research to the subjects? 
 
  The benefit of this research is that subjects’ supplementation may positively impact physical 
performance. The results of this study may aid in directing future research.  
 
4. Answer a), then answer either b) or c) as appropriate. 
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a. Describe how you will identify the subject population, and how you will contact key 
individuals who will allow you access to that subject population or database. 
  The sample will consist of men and women volunteers (age 18-35 years) from the local 
community, with no history of kidney, liver, or endocrine disease or dysfunction, and/or any 
other disorder that might affect normal cellular levels of creatine or fluid balance, and who 
have been cycling regularly (approximately three or more training sessions per week) for the 
past one year. Flyers will be posted in Wade King Student Rec Center and in Ridgeway 
Lounge (current location of strength equipment for Athletics). Also, local cycling shops and 
clubs will be contacted. We will obtain consent to post flyers. This method of recruitment has 
been used frequently in the past. 
b. Describe how you will recruit a sample from your subject population, including 
possible use of compensation, and the number of subjects to be recruited. 
 
  For this study, 36 women and men of 18-35 years of age will be recruited to participate. The 
first 36 will be invited to participate, with the remainder on a waitlist, if needed. Inclusion for 
this study demands that subjects be free of any kidney, liver, or endocrine disease or 
dysfunction, and/or any other disorders that might affect normal cellular levels of creatine or 
fluid balance, and who have been cycling regularly for the past one-year. Participants in this 
study will be compensated twenty dollars for their full participation. 
 
OR 
 
 
c. Describe how you will access preexisting data about the subjects. 
N/A 
5. Briefly describe the research methodology. Attach copies of all test 
instruments/questionnaires that will be used. 
Description of the Study Population 
  The study sample will consist of 36 apparently healthy, recreationally 18-35 year old active 
participants, half treatment (supplementation) and half placebo (carbohydrate solution).  The 
treatment will be a multi-ingredient performance supplement that contains creatine and 
electrolytes, sodium, potassium, calcium, and magnesium. Subjects will have cycling 
experience (approximately three or more training sessions per week) for the last one year. 
Subjects will be chosen randomly based on their volunteer responses to flyers posted around 
Western Washington University (WWU) campus and local cycling shops and clubs. Subjects 
will be randomly assigned to two groups, placebo and treatment; a multi-ingredient 
performance supplement, which includes creatine. Prerequisite to participation, each subject 
receives an informed consent form previously approved by the institution’s Human Subjects 
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Committee. Subjects who had supplemented creatine in their habitual diet within the 60 days 
prior to orientation or any who were suffering from any kidney, liver, or endocrine disease or 
any disorder that might affect normal cellular levels of creatine or fluid balance (or both) will 
be excluded. The medical history questionnaire will filter any subjects taking any substance 
classified as a diuretic other than caffeine in their habitual diet. Subjects will be instructed to 
keep exercise regimens consistent throughout the study with continued participation in their 
cycling program. Training logs will be maintained to confirm compliance. If a subject misses 
more than three supplement days, they will be dropped from the study.  
Procedures and Instrumentation 
 The baseline and posttest data included: height measured by stadiometer, weight using a 
balance beam scale, body water by bioelectrical impedance (BIA), body composition with 
skin fold measurement, physical activity profile, and specific cycling sprint tests described 
below. These measures will be repeated at the end of the study.  
Diet and Supplementation: The diet analysis aids in description of the study sample. Two 
separate 3-day diet records will be kept by the subjects and the records will be analyzed using 
Nutritionist Pro software (Axxya Systems, Stafford, TX). From this data, nutrient and energy 
levels will be determined. Supplementation will be given orally and provided by the 
manufacturer, with placebo appearance identical.  Subjects will be randomly assigned to 
groups (treatment, hence supplemented [S] with creatine and electrolytes similar to a sports 
drink and placebo [P] which is a carbohydrate solution), and these will be administered in a 
double blind fashion.  The treatment period will be six weeks to allow for tissue saturation.  
Body Water:  Total body water (TBW) and both intracellular and extracellular fluid 
compartments (ICF and ECF) will be determined with an RJL Quantum X bioimpedance 
unit. Electrodes will be placed on the right upper and lower extremities, at approximately the 
wrist and the third metacarpal plus the ankle and third metatarsal, respectively. This tool has 
been used to assess TBW and volume of body water compartments, with good reliability and 
validity [44-46]. The subjects will refrain from exercise for at least 12 hours prior to testing. 
For a full twenty four hours before body water testing, subjects will maintain hydration. All 
tests will be completed at the same time of day for each subject.  
Body Composition:  Body composition (i.e. percent body fat, fat free mass, and fat mass) will 
be assessed using a three-site skinfolds measurement technique. The measurement of 
skinfold thickness is a valid and reliable method for assessing body composition [67]. The 
same investigator will conduct all skinfold measurements Male and female subjects will be 
assessed by use of a three site skinfold test, which will provide the researchers with an 
estimate of the subject’s body density. The three sites used for male subjects will be the 
chest, triceps, and subscapular skinfolds. Female subjects will have skinfold measurements 
taken at the triceps, suprailiac, and abdomen. The sum of the three skinfold measurements 
will be entered into an age and race appropriate equation to estimate body density [68]. Once 
the subject’s body density has been estimated, a subsequent equation (Siri) will be used to 
estimate body composition based on body density [68].  
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Exercise Protocols:   Subjects will maintain their training throughout the course of the study. 
A physical activity log will be completed for each participant to assess the caloric 
expenditures of each subject during the two three-day diet log periods. This activity log is 
assigned a kilocalorie expenditure value per kilogram body weight in fifteen minute intervals 
to corresponding exertion levels of categorized physical activities, ranging in intensities from 
one to nine, with one being activities such as sleep and nine being activities such as heavy 
resistance exercise. This assessment is referred to as the 3-day the Bouchard method [47].  
Sprint Cycling Test:  Prior to the sprint testing, the subjects will complete a five-minute 
warm-up. The warm-up for male subjects will be comprised of pedaling at a constant 
workload of 100 W, and female subjects pedaling at a constant workload of 50 W. Following 
the five-minute warm-up, subjects will remain seated on the cycle ergometer for three 
minutes of passive recovery. The subjects will then complete a total of five, 15-second 
sprints, each followed by two minutes of passive recovery. The sprints will be performed at 
the subjects’ maximal cadence against a resistance relative to the subjects’ body mass (0.075 
kp per kg). A Velotron cycle ergometer, installed with instrumented bicycle pedals, will 
collect the dynamic propulsive cycling loads applied at the crank during each sprint cycling 
test. The collected data will be entered into I-Crankset software in order to determine peak 
power output and total work performed. 
6. Give specific examples (with literature citations) for the use of your test 
instruments/questionnaires, or similar ones, in previous similar studies in your field. 
  Sports drinks were the original prototype of multi-ingredient performance supplements 
(MIPS). Much recent research has been reported with various combinations of MIPS, 
complex mixes of nutrients with the common factor being creatine [2-8]. Creatine is a widely 
used supplement deemed safe by the International Society for Sports Nutrition. Safety 
information for this specific formulation is attached.  
 A Velotron cycle ergometer (Racer-Mate Inc., Seattle, WA) equipped with instrumented 
bicycle pedals (Sensix, Poitiers, France), which have digital encoders to monitor the cadence 
and crank and pedal angles, will be used to measure dynamic power applied to the crank arm 
during the sprint cycling testing procedures. The Velotron cycle ergometer is a valid and 
reliable tool that is used to measure parameters of cycling performance, including peak 
power output and total work performed [66]. Data collected from the instrumented pedals 
will be analyzed using I-Crankset software (Sensix, Poitiers, France) in order to determine 
peak power output and total work performed. 
7. Describe how your study design is appropriate to examine your question or specific 
hypothesis. Include a description of controls used, if any. 
  This study will follow a double blind, two-group format analyzed for a 6-week treatment 
period. These groups will consist of supplementation and placebo. Supplementation will be a 
creatine-electrolyte multi-ingredient performance supplement, or placebo (carbohydrate 
solution). Comparisons will between baseline and after 6-weeks of, between and within 
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groups, for the selected variables.  Testing procedures will be conducted at the same time of 
day, as much as possible, to avoid confounding factors. 
8. Give specific examples (with literature citations) for the use of your study design, or 
similar ones, in previous similar studies in your field. 
 
   A blinded, repeated measures design type is common in sports nutrition research. It has 
long been a recommended design [52] in this area of research. 
 
9. Describe the potential risks to the human subjects involved. 
 
  When conducting any physical activity there are risks of muscle, tendon, or ligament injury 
present. This possibility also exists for the cycling exercises in this project. 
 
10. If the research involves potential risks, describe the safeguards that will be used to 
minimize such risks. 
  Only subjects who have been cycling for a minimum of one year will be entered into the 
study. To ensure safety of subjects, a familiarization to the movements utilized in testing will 
be conducted. Multiple lab assistants familiar with the cycling protocols will be on hand to 
ensure proper testing procedures and safety during the warm–up and testing trials.  
Describe how you will address privacy and /or confidentiality. 
 Any and all data collected will be kept completely confidential and will be stored and 
analyzed by subject number only.  Only the primary researchers will have access to the 
records. The data will be stored separately from the informed consents to keep the identity 
anonymous. A locked cabinet will be used for hard copy and electronic data. 
 
11. If your research involves the use of schools (pre-kindergarten to university level) or 
other organizations (e.g., community clubs, companies), please attach a clearance 
letter from an administrator from your research site indicating that you have been 
given permission to conduct this research. For pre-kindergarten to grade 12 level 
schools, an administrator (e.g. principal or higher) should issue the permission. For 
post-secondary level schools the class instructor may grant permission. For Western 
Washington University, this requirement of a clearance letter is waived if you are 
recruiting subjects from a scheduled class. If you are recruiting subjects from a 
campus group (not a class) at Western Washington University, you are required to 
obtain a clearance letter from a leader or coordinator of the group. 
N/A 
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12. If your research involves the use of schools (pre-kindergarten to university level)or 
other organizations (e.g., community clubs, companies), and you plan to take still or 
video pictures as part of your research, please complete 
a) To d) below: 
a. Who have you contacted at the school district or organization involved, to determine 
the policy on the use of photography in the school or organization? 
 
N/A 
 
b. Explain how your research plan conforms to the policy on the use of photography in 
the school or organization. 
 
N/A 
 
c. Attach a copy of the school district or organization policy on the use of photography 
at the schools or organization. 
N/A 
d. Explain how you will ensure that the only people recorded in your pictures will be 
the ones that have signed a consent form. 
N/A 
In addition, please attach the following information: 
1. A bibliography relevant to the subject matter of the proposed research. 
See below 
2. A copy of the informed consent form (a checklist is attached for you to use as a 
guide) 
 
See below 
 
3. A current curriculum vitae. 
See below 
4. A copy of the certificate of completion for Human Subjects Training from the online 
human subjects training module, for each person involved in the research who will 
have any contact with the subjects or their data. 
See below 
5. If your subjects are required to turn in a physical clearance from prior to 
participation include a copy of the blank form. 
N/A 
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Pre-Supplementation 
 
Placebo 
 
Subject ID Sex Age (yr) Height (m) Mass (kg) 
AWC_002 Male 29 1.85 78.8 
AWC_003 Male 20 1.68 68.3 
AWC_005 Female 29 1.63 61.3 
AWC_008 Male 21 1.85 96.2 
AWC_009 Male 23 1.86 76.7 
AWC_012 Female 21 1.70 55.7 
AWC_013 Female 22 1.64 60.4 
AWC_017 Male 24 1.91 83.1 
AWC_018 Male 23 1.82 74.9 
AWC_019 Female 30 1.75 67.8 
AWC_021 Male 19 1.77 72.3 
AWC_023 Male 23 1.75 61.6 
AWC_028 Female 24 1.75 69.2 
AWC_031 Male 28 1.63 63.6 
AWC_033 Male 25 1.73 68.9 
AWC_035 Male 21 1.89 84.6 
AWC_036 Female 24 1.71 63.3 
AWC_038 Female 19 1.65 61.3 
n = 18     
Male: n = 11 
Female: n = 7 
Mean 23.6 1.75 70.4 
Standard Deviation 3.4 0.09 10.4 
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Creatine-Electrolyte 
 
Subject ID Sex Age (yr) Height (m) Mass (kg) 
AWC_001 Male 20 1.81 69.0 
AWC_006 Male 23 1.77 75.4 
AWC_007 Male 24 1.75 67.6 
AWC_010 Male 25 1.78 71.8 
AWC_014 Female 19 1.57 53.3 
AWC_015 Male 20 1.71 81.0 
AWC_016 Male 30 1.71 68.0 
AWC_020 Female 27 1.64 69.1 
AWC_022 Male 33 1.71 74.7 
AWC_025 Male 23 1.73 64.0 
AWC_026 Male 20 1.73 67.6 
AWC_027 Male 22 1.71 75.6 
AWC_029 Male 21 1.74 68.4 
AWC_030 Male 27 1.85 78.5 
AWC_032 Female 24 1.68 59.8 
AWC_034 Female 20 1.64 79.0 
AWC_037 Female 20 1.68 60.6 
n = 17     
Male: n = 12 
Female: n = 5 
Mean 23.4 1.72 69.6 
Standard Deviation 4.0 0.07 7.4 
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Post-Supplementation 
 
Placebo 
 
Subject ID Sex Age (yr) Height (m) Mass (kg) 
AWC_002 Male 29 1.83 77.2 
AWC_003 Male 20 1.68 68.0 
AWC_005 Female 29 1.63 59.8 
AWC_008 Male 21 1.84 90.7 
AWC_009 Male 24 1.86 76.5 
AWC_012 Female 21 1.70 56.8 
AWC_013 Female 22 1.64 59.5 
AWC_017 Male 25 1.92 81.9 
AWC_018 Male 23 1.84 72.3 
AWC_019 Female 30 1.75 67.8 
AWC_021 Male 19 1.77 72.6 
AWC_023 Male 23 1.75 62.0 
AWC_028 Female 24 1.76 70.3 
AWC_031 Male 28 1.64 62.9 
AWC_033 Male 25 1.75 67.4 
AWC_035 Male 21 1.89 86.3 
AWC_036 Female 24 1.71 64.0 
AWC_038 Female 19 1.65 60.8 
n = 18     
Male: n = 11 
Female: n = 7 
Mean 23.7 1.76 69.8 
Standard Deviation 3.4 0.09 9.6 
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Creatine-Electrolyte Group 
 
Subject ID Sex Age (yr) Height (m) Mass (kg) 
AWC_001 Male 20 1.81 70.4 
AWC_006 Male 23 1.77 78.0 
AWC_007 Male 24 1.75 68.6 
AWC_010 Male 25 1.77 73.8 
AWC_014 Female 19 1.57 54.7 
AWC_015 Male 20 1.70 85.8 
AWC_016 Male 30 1.72 70.6 
AWC_020 Female 27 1.65 70.1 
AWC_022 Male 33 1.72 75.9 
AWC_025 Male 23 1.73 65.9 
AWC_026 Male 20 1.73 68.6 
AWC_027 Male 22 1.71 74.8 
AWC_029 Male 21 1.75 69.5 
AWC_030 Male 28 1.86 78.7 
AWC_032 Female 24 1.69 61.7 
AWC_034 Female 20 1.63 78.3 
AWC_037 Female 20 1.68 60.8 
n = 17     
Male: n = 13 
Female: n = 5 
Mean 23.5 1.72 71.0 
Standard Deviation 4.0 0.07 7.6 
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Appendix E 
Peak Power Output and Total Work Data 
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Pre-Supplementation 
 
Placebo 
 
 Peak Power Output (W) Total Work (J) 
Subject ID Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 
AWC_002 758 740 763 764 727 10128 9689 10257 10259 9686 
AWC_003 729 703 684 641 647 9634 9558 9398 8691 8974 
AWC_005 515 517 492 478 468 7113 7034 6856 6617 6485 
AWC_008 834 796 793 769 777 11141 10658 10753 10698 10738 
AWC_009 799 759 692 656 641 10715 10380 9471 8998 8838 
AWC_012 484 458 422 403 -- 6012 5985 5537 5184 -- 
AWC_013 516 448 425 396 384 6567 5918 5926 5517 5392 
AWC_017 902 845 789 743 730 12082 11354 10792 9968 9882 
AWC_018 770 724 676 639 599 10029 9793 9114 8808 8180 
AWC_019 552 555 535 513 518 7310 7441 7305 6737 7005 
AWC_021 790 752 720 666 679 10439 10319 9900 9154 9328 
AWC_023 620 594 549 524 517 8302 7959 7288 7171 7023 
AWC_028 486 507 505 478 487 6665 7081 7085 6662 6798 
AWC_031 601 602 614 581 563 7618 8242 8365 7893 7478 
AWC_033 730 690 650 622 603 9906 9532 8858 8521 8121 
AWC_035 901 837 785 753 763 12522 11699 10891 10453 10546 
AWC_036 599 569 540 500 445 7660 7512 7216 6742 5798 
AWC_038 398 404 406 398 385 4549 4956 5042 4999 4659 
           
Mean 665.8 638.9 613.3 584.7 584.3 8799.4 8617.2 8336.2 7948.4 7937.1 
Standard 
Deviation 154.5 139.3 132.8 128.6 127.2 2236.8 1986.4 1870.8 1825.2 1812.1 
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Creatine-Electrolyte 
 
 Peak Power Output (W) Total Work (J) 
Subject ID Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 
AWC_001 684 683 650 622 599 8480 9213 8907 8497 7883 
AWC_006 798 796 789 770 760 10439 10791 10909 10425 10387 
AWC_007 638 654 616 611 599 8010 8669 8286 8215 8098 
AWC_010 739 655 584 518 509 9501 8859 7893 6958 6889 
AWC_014 453 437 415 395 386 5595 5738 5622 5303 5305 
AWC_015 739 662 586 537 486 9798 8878 8035 7419 6662 
AWC_016 665 643 612 591 591 9136 8956 8623 8205 8328 
AWC_020 636 589 559 522 504 8673 8124 7696 7179 6854 
AWC_022 771 734 662 590 548 10543 9985 9099 7860 6889 
AWC_025 673 627 574 544 519 8640 8307 7701 7286 6931 
AWC_026 693 632 614 586 553 9016 8390 8121 7835 7436 
AWC_027 812 752 691 645 617 11241 10644 9579 8834 8333 
AWC_029 678 641 587 494 -- 8581 8340 7694 6367 -- 
AWC_030 902 840 786 745 723 12409 11758 10869 10202 9799 
AWC_032 529 522 499 467 455 6349 6575 6568 6291 5996 
AWC_034 535 515 510 494 476 7342 7313 7031 6950 6674 
AWC_037 459 433 430 388 381 5493 5633 5792 5346 5225 
           
Mean 670.8 636.2 597.9 559.9 544.1 670.8 636.2 597.9 559.9 544.1 
Standard 
Deviation 123.2 113.1 103.0 103.9 104.3 123.2 113.1 103.0 103.9 104.3 
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Post-Supplementation 
 
Placebo 
 
 Peak Power Output (W) Total Work (J) 
Subject ID Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 
AWC_002 780 775 767 757 739 10644 10368 10447 10154 9818 
AWC_003 722 698 683 652 637 10047 9603 9438 9003 8721 
AWC_005 506 503 491 488 493 6895 6992 6832 6860 6967 
AWC_008 836 795 726 725 714 11499 10880 10145 10020 9898 
AWC_009 822 732 717 695 663 11376 9823 9781 9587 9140 
AWC_012 526 476 445 427 -- 6954 6323 5989 5827 -- 
AWC_013 524 483 451 432 428 6951 6552 6160 5974 5199 
AWC_017 894 859 811 791 798 12111 11656 10993 10858 10817 
AWC_018 776 719 688 652 637 10399 9854 9324 8926 8523 
AWC_019 563 555 539 539 525 7583 7283 7189 7218 7155 
AWC_021 814 784 727 690 608 10901 10670 9947 9449 8162 
AWC_023 647 619 585 540 524 8747 8403 7985 7070 6855 
AWC_028 494 493 487 471 462 6843 6971 6760 6649 6478 
AWC_031 553 528 529 532 511 7344 6935 7012 7238 6585 
AWC_033 718 687 670 638 589 9681 9205 9286 8782 7942 
AWC_035 925 869 839 806 803 12800 11882 11645 11123 11000 
AWC_036 609 579 553 532 516 8028 7715 7495 7217 6938 
AWC_038 415 408 400 389 367 5198 5191 5250 4756 4183 
           
Mean 673.6 642.3 617.1 597.6 589.1 9111.2 8683.5 8426.4 8150.6 7904.7 
Standard 
Deviation 155.1 144.1 135.4 130.9 127.1 2213.7 2008.8 1906.4 1854.7 1883.6 
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Creatine-Electrolyte 
 
 Peak Power Output (W) Total Work (J) 
Subject ID Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 Sprint 1 Sprint 2 Sprint 3 Sprint 4 Sprint 5 
AWC_001 705 681 657 609 612 9524 9343 9291 8214 8332 
AWC_006 836 833 820 798 799 11396 11216 11200 11100 10948 
AWC_007 641 617 621 611 607 8685 8555 8555 8516 8367 
AWC_010 801 677 598 535 519 10595 9119 8076 7234 6888 
AWC_014 464 443 419 397 396 6176 5848 5606 5262 5199 
AWC_015 811 714 632 541 509 10791 9485 8403 7405 6938 
AWC_016 730 682 650 645 628 10351 9656 9040 9109 8885 
AWC_020 609 603 582 560 555 7913 7976 7649 7536 7410 
AWC_022 810 743 665 611 552 10956 10039 8997 8329 7232 
AWC_025 680 668 648 618 593 9298 9061 8755 8277 8045 
AWC_026 743 667 581 519 500 9837 9085 8010 7013 6576 
AWC_027 789 784 751 701 703 10833 10598 10204 9715 9698 
AWC_029 736 669 566 499 -- 9684 8883 7567 6601 -- 
AWC_030 892 857 818 771 762 12299 11788 11275 10725 10458 
AWC_032 572 550 527 513 494 7354 7295 6970 6835 6661 
AWC_034 552 529 525 512 529 7685 7355 7310 7107 7510 
AWC_037 501 443 388 364 374 6848 6054 5403 5013 5222 
           
Mean 698.4 656.5 614.6 576.7 570.8 9424.9 8903.2 8371.3 7881.8 7773.0 
Standard 
Deviation 124.4 118.2 117.1 114.7 116.0 1735.2 1628.9 1631.5 1660.7 1648.3 
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Appendix F 
Body Composition Data 
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Pre-Supplementation 
 
Placebo 
 
Subject ID Body Mass (kg) Percent Body Fat (%) Fat Mass (kg) Fat Free Mass (kg) 
AWC_002 78.8 6.9 5.4 73.3 
AWC_003 68.3 6.2 4.3 64.1 
AWC_005 61.3 21.3 13.0 48.3 
AWC_008 96.2 19.7 18.9 77.3 
AWC_009 76.7 5.8 4.4 72.3 
AWC_012 55.7 17.7 9.8 45.9 
AWC_013 60.4 21.2 12.8 47.6 
AWC_017 83.1 6.7 5.6 77.5 
AWC_018 74.9 18.1 13.6 61.3 
AWC_019 67.8 23.2 15.7 52.1 
AWC_021 72.3 4.7 3.4 68.9 
AWC_023 61.6 5.1 3.2 58.5 
AWC_028 69.2 29.5 20.4 48.8 
AWC_031 63.6 4.6 2.9 60.7 
AWC_033 68.9 4.4 3.0 65.9 
AWC_035 84.6 7.9 6.7 77.9 
AWC_036 63.3 15.2 9.6 53.7 
AWC_038 61.3 26.9 16.5 44.8 
     
Mean 70.4 13.6 9.4 61.0 
Standard 
Deviation 10.4 8.6 5.9 11.7 
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Creatine-Electrolyte 
 
Subject ID Body Mass (kg) Percent Body Fat (%) Fat Mass (kg) Fat Free Mass (kg) 
AWC_001 69.0 6.7 4.6 64.4 
AWC_006 75.4 4.5 3.4 72.0 
AWC_007 67.6 5.3 3.6 64.1 
AWC_010 71.8 8.2 5.9 66.0 
AWC_014 53.3 19.3 10.3 43.1 
AWC_015 81.0 15.7 12.7 68.3 
AWC_016 68.0 5.6 3.8 64.2 
AWC_020 69.1 28.7 19.8 49.3 
AWC_022 74.7 4.6 3.4 71.2 
AWC_025 64.0 5.8 3.7 60.3 
AWC_026 67.6 4.3 2.9 64.7 
AWC_027 75.6 8.3 6.3 69.3 
AWC_029 68.4 7.9 5.4 63.0 
AWC_030 78.5 7.8 6.1 72.4 
AWC_032 59.8 16.6 9.9 49.9 
AWC_034 79.0 31.5 24.9 54.1 
AWC_037 60.6 18.5 11.2 49.4 
     
Mean 69.6 11.7 8.1 61.5 
Standard 
Deviation 7.4 8.6 6.2 9.1 
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Post-Supplementation 
 
Placebo 
 
Subject ID Body Mass (kg) Percent Body Fat (%) Fat Mass (kg) Fat Free Mass (kg) 
AWC_002 77.2 5.3 4.1 73.1 
AWC_003 68.0 4.5 3.1 64.9 
AWC_005 59.8 20.1 12.0 47.8 
AWC_008 90.7 14.8 13.4 77.3 
AWC_009 76.5 5.3 4.0 72.5 
AWC_012 56.8 18.0 10.2 46.5 
AWC_013 59.5 20.5 12.2 47.3 
AWC_017 81.9 7.3 6.0 76.0 
AWC_018 72.3 13.7 9.9 62.4 
AWC_019 67.8 20.8 14.1 53.6 
AWC_021 72.6 5.2 3.8 68.9 
AWC_023 62.0 4.5 2.8 59.2 
AWC_028 70.3 29.7 20.8 49.4 
AWC_031 62.9 5.0 3.2 59.7 
AWC_033 67.4 4.1 2.7 64.7 
AWC_035 86.3 9.5 8.2 78.1 
AWC_036 64.0 15.9 10.2 53.8 
AWC_038 60.8 28.7 17.5 43.4 
     
Mean 69.8 12.9 8.8 61.0 
Standard 
Deviation 9.6 8.5 5.5 11.6 
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Creatine-Electrolyte 
 
Subject ID Body Mass (kg) Percent Body Fat (%) Fat Mass (kg) Fat Free Mass (kg) 
AWC_001 70.4 6.1 4.3 66.1 
AWC_006 78.0 3.2 2.5 75.5 
AWC_007 68.6 4.1 2.8 65.7 
AWC_010 73.8 7.3 5.4 68.4 
AWC_014 54.7 18.9 10.4 44.3 
AWC_015 85.8 17.1 14.7 71.1 
AWC_016 70.6 5.3 3.7 66.9 
AWC_020 70.1 29.4 20.6 49.5 
AWC_022 75.9 4.9 3.7 72.2 
AWC_025 65.9 5.5 3.6 62.3 
AWC_026 68.6 4.5 3.1 65.5 
AWC_027 74.8 8.0 6.0 68.8 
AWC_029 69.5 6.5 4.5 64.9 
AWC_030 78.7 8.2 6.5 72.2 
AWC_032 61.7 16.2 10.0 51.7 
AWC_034 78.3 32.8 25.7 52.6 
AWC_037 60.8 15.6 9.5 51.3 
     
Mean 71.0 11.4 8.1 62.9 
Standard 
Deviation 7.6 9.0 6.6 9.3 
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Appendix G 
Body Water Data 
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Pre-Supplementation 
 
Placebo 
 
Subject ID Total Body Water (liters) 
Intracellular Water 
(liters) 
Extracellular Water 
(liters) 
AWC_002 48.4 28.1 20.3 
AWC_003 47.7 28.5 19.1 
AWC_005 36.3 19.6 16.7 
AWC_008 51.6 28.8 22.8 
AWC_009 48.6 28.1 20.5 
AWC_012 30.2 16.1 14.1 
AWC_013 30.1 16.3 13.8 
AWC_017 51.8 29.7 22.1 
AWC_018 47.0 27.3 19.7 
AWC_019 36.8 19.2 17.7 
AWC_021 43.1 25.2 18.0 
AWC_023 40.8 24.3 16.5 
AWC_028 33.8 17.6 16.3 
AWC_031 40.7 24.4 16.3 
AWC_033 46.3 27.2 19.2 
AWC_035 50.2 28.9 21.3 
AWC_036 33.5 18.0 15.5 
AWC_038 29.2 17.1 12.1 
    Mean 41.5 23.6 17.9 
Standard 
Deviation 7.9 5.1 3.0 
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Creatine-Electrolyte 
 
Subject ID Total Body Water (liters) 
Intracellular Water 
(liters) 
Extracellular Water 
(liters) 
AWC_001 41.3 24.2 17.1 
AWC_006 44.1 25.6 18.5 
AWC_007 42.7 25.2 17.5 
AWC_010 43.8 25.5 18.3 
AWC_014 26.8 14.4 12.3 
AWC_015 45.3 24.0 21.3 
AWC_016 39.6 23.1 16.6 
AWC_020 34.4 18.0 16.4 
AWC_022 52.3 30.6 21.7 
AWC_025 39.7 23.6 16.1 
AWC_026 41.1 24.5 16.5 
AWC_027 41.8 24.4 17.4 
AWC_029 40.3 23.8 16.5 
AWC_030 47.6 27.1 20.5 
AWC_032 33.0 17.6 15.4 
AWC_034 36.4 18.8 17.7 
AWC_037 29.2 15.1 14.1 
    
Mean 40.0 22.7 17.3 
Standard 
Deviation 6.5 4.4 2.4 
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Post-Supplementation 
 
Placebo 
 
Subject ID Total Body Water (liters) 
Intracellular Water 
(liters) 
Extracellular Water 
(liters) 
AWC_002 46.5 27.1 19.4 
AWC_003 45.7 27.5 18.2 
AWC_005 34.0 18.4 15.6 
AWC_008 47.7 26.8 20.9 
AWC_009 46.6 27.1 19.5 
AWC_012 31.1 16.7 14.4 
AWC_013 29.9 16.0 13.9 
AWC_017 50.4 28.7 21.7 
AWC_018 47.5 27.6 19.9 
AWC_019 35.5 18.4 17.1 
AWC_021 41.1 23.9 17.2 
AWC_023 37.5 22.3 15.2 
AWC_028 34.0 19.4 14.6 
AWC_031 37.8 22.7 15.1 
AWC_033 45.7 26.9 18.8 
AWC_035 50.5 28.9 21.6 
AWC_036 36.2 19.6 16.6 
AWC_038 27.5 14.3 13.2 
    Mean 40.3 22.9 17.4 
Standard 
Deviation 7.4 4.9 2.7 
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Creatine-Electrolyte 
 
Subject ID Total Body Water (liters) 
Intracellular Water 
(liters) 
Extracellular Water 
(liters) 
AWC_001 41.9 24.7 17.2 
AWC_006 45.8 26.7 19.1 
AWC_007 45.4 27.0 18.3 
AWC_010 45.1 26.5 18.6 
AWC_014 26.9 14.5 12.4 
AWC_015 48.0 27.4 20.6 
AWC_016 41.6 24.3 17.3 
AWC_020 35.3 18.5 16.8 
AWC_022 51.2 29.9 21.3 
AWC_025 40.2 24.0 16.2 
AWC_026 40.5 24.2 16.3 
AWC_027 42.3 24.8 17.5 
AWC_029 38.2 22.5 15.7 
AWC_030 37.9 21.2 16.7 
AWC_032 33.8 18.2 15.7 
AWC_034 36.0 18.6 17.4 
AWC_037 28.0 14.4 13.7 
    
Mean 39.9 22.8 17.1 
Standard 
Deviation 6.6 4.5 2.2 
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Appendix H 
Energy Expenditure and Dietary Intake Data 
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Placebo 
 
Subject ID Energy Expended (Kcal.d-1) 
Dietary Energy Intake 
(Kcal.d-1) 
Dietary Carbohydrate 
(g.d-1) 
Dietary Fat 
(g.d-1) 
Dietary Protein 
(g.d-1) 
AWC_002 3441.4 1878.9 231.5 64.0 94.3 
AWC_003 3525.2 2244.6 268.5 81.7 108.8 
AWC_005 3668.0 2903.3 349.0 135.4 72.2 
AWC_008 4345.4 1964.0 186.8 90.8 99.9 
AWC_009 3204.5 2708.8 309.3 112.9 114.0 
AWC_012 2646.4 3696.4 325.4 215.4 114.1 
AWC_013 2900.1 2651.0 255.2 136.9 99.6 
AWC_017 3947.2 3110.4 368.7 125.2 127.3 
AWC_021 2975.8 2149.4 211.8 98.0 104.9 
AWC_023 2620.7 3137.6 407.2 117.4 113.2 
AWC_028 4102.9 1589.3 180.3 73.1 52.6 
AWC_031 2689.2 2292.4 232.3 99.6 116.7 
AWC_035 2946.1 1853.9 180.8 91.0 78.0 
AWC_036 3010.0 2985.2 311.1 147.0 104.5 
AWC_038 2377.8 965.6 102.5 44.5 38.8 
      Average 3226.7 2408.7 261.4 108.8 95.9 
Standard 
Deviation 590.3 709.9 83.4 41.1 25.0 
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Creatine-Electrolyte 
 
Subject ID Energy Expended (Kcal.d-1) 
Dietary Energy Intake 
(Kcal.d-1) 
Dietary Carbohydrate 
(g.d-1) 
Dietary Fat 
(g.d-1) 
Dietary Protein 
(g.d-1) 
AWC_001 3586.8 3161.0 390.5 119.8 130.1 
AWC_006 3194.3 2623.0 338.4 99.7 92.9 
AWC_007 3897.8 1952.9 161.0 79.4 148.7 
AWC_010 3649.7 2038.6 271.2 66.0 89.9 
AWC_014 2367.9 1357.6 165.7 45.1 72.2 
AWC_015 3731.9 1655.2 211.1 60.3 67.1 
AWC_016 3238.2 4654.3 542.2 150.8 282.1 
AWC_020 3254.0 3389.5 397.3 141.5 131.7 
AWC_025 -- 1894.4 243.0 65.6 82.9 
AWC_026 3207.5 2950.4 301.8 128.0 147.7 
AWC_027 3803.0 2679.9 333.8 96.7 118.6 
AWC_032 2448.2 2324.2 182.1 131.0 104.3 
AWC_034 3757.3 1983.5 188.6 98.9 84.9 
AWC_037 2595.7 1600.0 150.6 66.3 100.2 
      Average 3287.1 2447.5 277.0 96.4 118.1 
Standard 
Deviation 526.3 880.8 114.2 33.7 54.1 
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Appendix I 
Statistics 
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Peak Power Output 
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Total Work 
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Body Mass 
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Fat Free Mass 
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Extracellular Water 
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Peak Power Output – Fat Free Mass Correlation 
 
 
 
Correlationsa 
 diff_power diff_lean_mass 
diff_power Pearson Correlation 1 .415 
Sig. (2-tailed)  .087 
N 18 18 
diff_lean_mass Pearson Correlation .415 1 
Sig. (2-tailed) .087  
N 18 18 
a. Supplement = Placebo 
 
 
 
 
Correlationsa 
 diff_power diff_lean_mass 
diff_power Pearson Correlation 1 .625** 
Sig. (2-tailed)  .007 
N 17 17 
diff_lean_mass Pearson Correlation .625** 1 
Sig. (2-tailed) .007  
N 17 17 
**. Correlation is significant at the 0.01 level (2-tailed). 
a. Supplement = MIPS 
 
 
 
